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11 INTRODUCTION
Most  drugs  today  are  developed  to  be  used  through  the  oral  route  of  administration 
(Lipinski et al. 2001). Screening of physicochemical factors, affecting oral bioavailability, 
are thus of high importance in drug discovery and development. One of the most important 
of these physicochemical factors is the dissolution rate of a drug substance. The potential of 
mini-scale  dissolution  tests,  for  drug  discovery  and  early  development,  lies  in  the 
opportunity  of  obtaining  large  amounts  of  quantitative  data,  from  small  amounts  of 
substance.  At  the  present,  these  early  assessments  are,  however,  performed  through 
qualitative experiments,  such  as  kinetic  solubility assays  (Sugano et  al  2007).  In  silico 
computational tools are another largely used method for early qualitative characterization of 
new drug substances (Curatolo 1998). The reason why dissolution testing has not been used 
in a larger scale, for early quantitative physicochemical assessment, might be due to the 
lack of appropriate technological approaches for mini-scale dissolution testing (Gardner et 
al. 2004). The development of new small-scale dissolution techniques, therefore poses an 
interesting opportunity. While the general way of studying drug dissolution has been by the 
multipartuculate bulk approach, studying the single particles of these systems could give a 
deeper understanding of the core factors affecting the dissolution rate of drug substances 
(Marabi  et  al.  2008;  de Villiers  1996).  The  aim of  the  present  study was therefore,  to 
develop a mini-scale dissolution method, for assessing the dissolution of single particles.
2 DISSOLUTION
A substance is  regarded as dissolved when it  has become molecularly dispersed in  the 
solvent  (Martin  et  al.  2011).  In  addition  to  a  molecular  monomer  form,  the  dissolved 
substance can also exist in solution as a self-aggregated form, of two or more molecules, 
2and,  in  solutions  including  more  substances,  as  complexes  or  included  into  micelles 
(Sugano et al. 2007). Nanosuspensions can also, sometimes, be regarded as solutions. The 
dissolution process, of a solid in a liquid, involves two steps. First a molecule is dissociated 
from the solid surface due to energetic interactions with solvent molecules, after which the 
dissociated molecule diffuses into the bulk solution. The rate of dissociation of a molecule 
from the solid surface depends on the strength of the intermolecular interactions of solvate 
and solvent  molecules,  respectively,  and  the  strength  of  the  intermolecular  interactions 
between  solute  and  solvent  molecules  (Martin  et  al.  2011).  These  interactions  are  for 
example van der Waals, dipole-dipole, ion-dipole interactions and, as often in the case of 
aqueous solutions, hydrogen-bonds. It is thus the strength of the affinities of molecules to 
each other, inside the different substances and between the substances, that determines the 
overall dissociation rate. 
As  the  dissolution  process  is  inherently  a  process  of  dissociation  and  diffusion,  the 
dissolution rate is,  accordingly,  also determined by the accompanying rates of diffusion 
(Nernst 1904). The diffusional mass transfer process describes the random movement of 
molecules, the so called Brownian motion that results in a transportation of matter from one 
part of a system to another (Crank 1975). In 1855 Fick was able to derive the mathematical 
equation  (Equation  1)  describing  this  diffusional  flux,  by  identifying  the  similarity  of 
diffusion and heat conduction, the latter of which already had an equation established by 
Fourier in 1822 (Crank 1975; Fick 1855). 
            dxDdCJ /−=                                                      (1)
In this Fick's I law of diffusion,  J symbolizes the rate of transfer per unit area,  D is the 
diffusion  coefficient  and  dC/dx expresses  the  one-directional  change  of  concentration 
through  the  distance  dx (Crank  1975;  Hixson  and  Crowell  1931).  The  equation  can 
subsequently be rewritten as,
3dxDAdCdtdm // −=                                                 (2)
where dm/dt expresses the amount of diffusing solute per time through the area A and the 
rest of the symbols are as above (Hixson and Crowell 1931).
The  diffusion  coefficient  D can  be  determined  from experimental  results.  However,  a 
theoretical  diffusion coefficient  for  a  spherical  particle  was also derived by Einstein in 
1905,
 r
Tk
D B
pi η6=                                                          (3)
where kB is the Bolzmann constant, T is the temperature, η is the viscosity of the medium in 
which diffusion takes place and  r  is the hydrodynamic radius of the diffusing molecule 
(Einstein 1905; Higuchi 1967). This so called Stokes-Einstein relation is usable when the 
solvent molecules are of similar dimension with the solute molecules (Higuchi 1967).
2.1 Three physical models of dissolution
There are three physical models that are commonly used to model the dissolution of a pure 
solid substance in a homogeneous solvent (Higuchi 1967). These models are the diffusion 
layer model, the interfacial barrier model and Dankwerts' surface renewal model (Figure 1). 
The diffusion layer model assumes that the dissociation reaction at the interface of solute 
and solvent is much faster than the Brownian diffusion or convective rate of transport into 
the  bulk  solution  (Wurster  and  Taylor  1965).  Thus  there  exists  a  diffusion  layer  of 
thickness,  h around the  solid  surface  (Nernst  1904;  Higuchi  1967).  At  the  solid  liquid 
interface  saturation  concentration  is  assumed  and  outside  the  diffusion  layer  the  bulk 
concentration is assumed to be constant throughout. Thus, the concentration gradient inside 
4the diffusion layer becomes the rate limiting driving force of dissolution (Figure 1). This 
relationship was also derived by Noyes and Whitney in what has subsequently become the 
classical Noyes-Whitney equation (4) for expressing the dissolution rate,
)(/ tS CCkdtdC −=                                                (4)
where  k is  a constant,  dC/dt expresses the change in concentration with time,  Cs  is the 
equilibrium solubility and Ct is the concentration in the bulk solution at time t (Noyes and 
Whitney 1897).
Figure 1. Illustrations of the concentration gradient change in the diffusion layer model 
(left),  the  interfacial  barrier  model  (center),  and  the  solvent  packet  transport  of  the 
Dankwerts' surface renewal model (right) (modified from Higuchi 1967).
The Noyes-Whitney equation  was  subsequently  modified  by Brünner  and Tolloczko to 
include the surface area, A of the dissolving interface (Brünner and Tolloczko 1900),
)(/ tS CCkAdtdC −=                                              (5)
5and later with the aid of Fick's law of diffusion Brünner, while working for Nernst, was 
able to relate the constant,  k with the diffusion rate constant,  D  to establish the Nernst-
Brünner equation, 
)(/ tS CCVh
DA
dtdC −=                                              (6)
where A is the surface area of the dissolving substance or of the diffusion layer, h and V is 
the volume of the solvent (Nernst 1904, Brünner 1904). Although the diffusion layer model 
has been the most  prominent  model  used to  describe dissolution,  it  has been criticized 
throughout its existence (Wurster and Taylor 1965; Dokoumetzidis et al. 2008). The main 
point of criticism has been the assumption of the relatively instant formation of saturation 
concentration at the solid-liquid interface.
The interfacial barrier model, on the contrary,  assumes that the activation energy of the 
interfacial transport step is high, and consequently that the reaction rate at the solid-liquid 
interface is much slower than the rate of transport into the bulk solvent (Wurster and Taylor 
1965;  Higuchi  1967).  The  interfacial  reaction  of  dissociating  solute  molecules  into  the 
solvent  thus  becomes  the  rate  limiting  step  (Figure  1).  In  this  model  saturation 
concentration at the solid-liquid interface may not be assumed, and it becomes much more 
difficult to derive a rate law (Higuchi 1967). The rate law can however be expressed as,
)( tSi CCkj −=                                                     (7)
where j is the dissolution rate per unit area, ki is the effective interfacial transport rate and 
the other symbols are explained above.
6The Dankwerts' surface renewal model takes another approach. It models packets of solvent 
that diffuse to the solid interface, absorb solute molecules and are subsequently replaced by 
new solvent packets (Figure 1) (Dankwerts 1951; Higuchi 1967). The rate limiting step in 
this model thus becomes the rate of solvent transport to the solid interface and the rate law 
can be expressed as,
 j = S1/3D1/3(Cs - Ct)                                                   (8)
where S is the mean rate of solvent transport i.e. surface renewal (Higuchi 1967).
2.2 Three single particle models of dissolution, and beyond
All of the above models assume dissolution from a constant surface area. Realizing that the 
reaction rate is directly proportional to the surface area available for reaction, Hixson and 
Crowell (1931) saw the need for a rate law incorporating this fact. Since the surface area is 
related to the weight,  w of a particle, through volume and density, Hixson and Crowell 
started their derivation from the formula,
                            dw/dt = -KA(Cs – Ct)                                                   (9)
where  dw/dt expresses the change in weight of a particle with time. Substituting  Ct with 
(w0-w)/V and Cs with ws /V, where w0 is the initial weight of the dissolving particle, w is the 
weight of the particle at time t and ws is the weight needed for achieving saturation, gives,
 V(dw/dt) = -KA(ws – w0 + w)                                          (10)
and  ultimately  the  general  solution,  the  Hixson  Crowell  cube  root  law  is  arrived  at, 
following integration,
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where a = (ws – w0)1/3, b = w0  1/3 and x = w 1/3. Thus, the ”cube root law” name reflects the 
fact that the cube root of the weight at a specific time is the only variable, while all the 
other terms in the equation are constant. 
In the special case where the concentration change is negligible due to the maintenance of 
sink conditions, the term (Cs – Ct) can be assumed constant and is thus integrated into the 
Hixson-Crowell rate constant, K (Equation 13) (Hixson and Crowell 1931). Subsequently, 
the dissolution rate becomes dependent only on the surface area and Equation 11 is written 
as, 
     Kt = w0 1/3 - w 1/3,                                                                                   (12)
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where ρ is the density of the particle and the rest of the symbols are as above (Wang and 
Flanagan 1999).
For the modeling of dissolution of single spherical particles, two other models are also used 
(Wang and Flanagan 1999). From the basic form,
8tkww x
xx
−= 0                                                    (14)
 
where kx is a model specific rate constant, the three models are derived by substituting the 
exponent, x with ⅓, ½ or ⅔, the first one of these obviously being the Hixson-Crowell cube 
root law. The Hixson-Crowell cube root law, as all the previously mentioned equations, 
does not accurately model the dissolution rate for diminishing particles, since it assumes a 
constant diffusion layer thickness (Macheras and Dokoumetzidis 2000). As will be later 
discussed, the diffusion layer thickness does in fact change with particle size. The other two 
equations  with  square-root  and  two-thirds-root  dependency on  weight  were  derived  by 
Niebergall et al. (1963) and Higuchi & Hiestand (1963) respectively. These two models do 
not  either  take  into  account  the  changing diffusion  layer  thickness,  but  they do model 
different phases of the single particle dissolution better than the Hixson-Crowell cube-root 
law (Wang and Flanagan 1999). While the Hixson-Crowell cube-root expression accurately 
models the dissolution of spherical particles, larger than the diffusion layer thickness, the 
square-root variation is more accurate for particles of the same size as the diffusion layer 
thickness.  For  particles  smaller  than  the  diffusion  layer  thickness  the  two-thirds-root 
dependency is the most appropriate.
One model that does take the diminishing diffusion layer into account was derived by Wang 
and Flanagan (2002),
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where r0 is the initial particle radius and r is the radius at time t (Wang and Flanagan 1999). 
The equation has been successful in modeling the dissolution of single particles over the 
whole size range (Wang and Flanagan 2002). Another model that has been successful in 
modeling dissolution rates over a wide range is the empirical Weibull function, 
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where m is the accumulated fraction of drug dissolved at time t, Ti is the dissolution onset 
lag time, a is a time scale parameter and b expresses the dissolution curve shape parameter 
(Costa and Sousa Lobo 2001). The equation has however been criticized for its lack of a 
physical  basis,  and  because  of  this  general  nature,  it  is  not  able  to  model  dissolution 
kinetics other  than descriptively.  Adding to  the equations mentioned above there exists 
several  other  formulas  that  describe  the  dissolution  process.  For  the  more  complex 
dissolution processes connected to the diffusion in and from semi-solid and solid matrices 
the work done by T. Higuchi is most notable. 
2.3 The intrinsic dissolution rate
The intrinsic dissolution rate (IDR) gives the dissolved amount of pure drug substance per 
surface area and time, and is determined by the mass transfer from the solid phase into the 
liquid,  during  constant  temperature,  pH,  ionic  strength  and  agitation  (United  States 
Pharmacopoeia (USP) 2001; Nicklasson and Magnusson 1985; Yu et al. 2004). To measure 
this propensity the effect of diffusion has to be eliminated through the maintenance of sink 
conditions, and the surface area of the dissolving solid is usually kept constant throughout 
the experiment.  As a consequence of these fixations in the experiment setup, when the 
cumulative  dissolved  amount  of  substance  per  surface  area  (usually  mgcm-2)  is  plotted 
against time (usually in minutes), a straight line is acquired. The slope of this line gives the 
IDR. Usually only the data of the first 10% of the IDR test is used (USP 2001). The IDR, j 
can be expressed with the following equation,
10
Adt
VdC
j =                                                          (17)
with the symbols explained above (Yu et al. 2004). When assessing the IDR with a rotating 
disc Wood's apparatus, the IDR can be acquired by the semi-empirical Levich equation,
SCv
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where  ω is  the angular velocity of the rotating disc and  ν the kinematic viscosity of the 
solvent  (Levich 1962). Because the initial  dissolution rate is  only limited by the mass 
transfer from solid to solvent, i.e. in many cases the solubility of a compound, the IDR can 
be  used  to  predict  the  order  of  magnitude  of  equilibrium solubilities  (Nicklasson  and 
Magnusson 1985). Additionally, the data can be used to calculate the diffusion coefficient, a 
pH-dissolution rate profile, pKa, the activation energy of interfacial mass transfer and the 
relation between dissolution rate and solid form (Nicklasson and Magnusson 1985 ; Yu et 
al. 2004). 
3 SOLUBILITY 
In contrast to the kinetic nature of dissolution, solubility is an equilibrium event determined 
by the opposite kinetic rates of dissolution and crystallization. The equilibrium can thus be 
expressed with the aid of a similar rate law as the one used for chemical kinetics (Equation 
19) (Dokoumetzidis et al. 2008). 
                  cnba kk  →←+ − 11 /                                                   (19)
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In this rate law a molecule of the dissolving solute,  a forms a solvent-solute complex, c  
with n solvent molecules, b driven by the rate constant k1 (Figure 2). The inverse process of 
crystallization,  where  solute-solvent  complexes  dissociate  and  new  solid  surface  is 
produced through recrystallization, is governed by the inverse rate constant k-1. Equilibrium 
is consequently achieved when the opposing rates are equal. Since the kinetic energy of 
molecules  is  dependent  on  temperature,  the  rate  constants,  and  thus  the  equilibrium 
solubility, are also temperature dependent (Bhattachar et al. 2006).
Figure 2. The interactions of solute and solvent molecules (left) result in the formation of 
new solute-solvent complexes (right) (from Bhattachar et al. 2006).
The  term  solubility  generally  refers  to  thermodynamic  equilibrium  solubility.  Using 
Equation 19 thermodynamic solubility can be explained as the point, with constant volume, 
pressure and temperature, at which the rate of dissolution and recrystallization of the most 
stable  crystal  form are  equal  and,  accordingly,  the  concentration  of  the  solution  keeps 
constant  (Bhattachar  et  al.  2006;  Sugano  et  al.  2007;  Kerns  et  al.  2008).  For  this 
equilibrium to  be  determined an  excess  amount  of  solid  has  to  be  in  contact  with  the 
solvent, and constant concentration has to be determined over long periods of time, usually 
several hours to days (Alsenz and Kansy 2007; Sugano et al. 2007).
Sufficient incubation time is important when measuring thermodynamic solubility, since all 
metastable physical forms will eventually recrystallize as the most stable crystal form, and 
thus the solid form with the lowest solubility (Bhattachar et al. 2006). When the incubation 
times are too short the measured solubility can, intentionally or not, be that of a metastable 
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physical form and is then called apparent solubility. Apparent solubility can also mean the 
result  from experiments using shorter  timescales (from a few, up to 24 hours), that  are 
chosen on the basis of what is thought to be enough to reach equilibrium (Sugano et al. 
2007). The solubility measurement in these experiments is done at the end of these time 
periods.  This  experimental  setup  is  especially applicable  in  early drug  discovery when 
faster, preliminary results are needed. 
Another often used method to assess the solubility of a compound in early drug discovery is 
to measure the kinetic solubility (Sugano et al. 2007). The time scale of these tests ranges 
from minutes to hours, and is significantly shorter than equilibrium solubility incubation 
times.  Kinetic solubility is often determined from pre-dissolved compounds in dimethyl 
sulfoxide (DMSO) stock solutions, making it in fact a measure of precipitation tendency. 
The reason why apparent solubility and kinetic solubility are not accurate measurements of 
equilibrium solubility, is the substantial risk of supersaturation in these measurements. The 
short incubation times might not be enough to settle at equilibrium, and the presence of a 
co-solvent, such as DMSO, can drive the concentration to supersaturation. This makes the 
results unreliable and incomparable with equilibrium solubility, since one cannot be sure if 
the solubility measured is the equilibrium solubility of the most stable crystal form, or in 
fact the higher apparent solubility of a metastable form (Bhattachar et al. 2006; Sugano et 
al. 2007). 
A fourth form of solubility is the intrinsic solubility. This is the solubility of the unionized 
state of a compound and should not be confused with intrinsic dissolution rate (Sugano et 
al. 2007). For ionizable substances this solubility is thus measured at suitable pH, where the 
compound does not dissociate. The intrinsic equilibrium solubility, S0  can be expressed by 
the Yalkowsky General Solubility Equation,
logS0 = 0.5 - logKo/w - 0.01(MP – 25)                                   (20)
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where logKo/w is the logarithmic partition coefficient between octanol and water and MP is 
the melting point,  i.e. the measure of the energy required to dissociate molecules in the 
crystal lattice (Jain and Yalkowsky 2001). This equation shows that the intrinsic solubility 
of  a  compound  is  dependent  on  the  lipophilicity  and  crystal  lattice  energies  of  that 
compound.
4 FACTORS AFFECTING THE DISSOLUTION RATE AND SOLUBILITY IN 
AQUEOUS MEDIA – IN VITRO AND IN VIVO
While dissolution rate and solubility are tightly linked, and slow dissolution rate reflects 
low solubility when no chemical reaction accompanies the dissolution process, there are 
differences in the factors governing them (Florence and Attwood 2011). The equilibrium 
solubility  and  dissolution  rate  of  a  compound  are  determined  by  the  physicochemical 
properties of the solute and solvent as well as the thermodynamic condition of the system 
(Martin et al. 2011). Dissolution rate is to a greater extent than solubility also governed by 
physical factors such as crystallinity, crystal form, particle size etc. These extrinsic factors 
do  not  change  the  equilibrium solubility  but  they  can  have  an  effect  on  the  apparent 
solubility of a substance. Factors that affect the dissolution rate and solubility of a drug 
substance  in  vivo include  physicochemical  properties  of  the  active  pharmaceutical 
ingredient  (API),  excipients,  formulation,  and  the  gastrointestinal  (GI)  tract  conditions 
(Dressman et al. 1998). Some of the factors (e.g. temperature, cosolvents and incubation 
time) have already been discussed, and below some further important factors are expanded 
upon.
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4.1 Sink conditions
Dissolution under sink conditions refers to the dissolution under such circumstances where 
the concentration of dissolved compound does not affect the dissolution rate of undissolved 
compound  (Mosharraf  and  Nystrom  1995).  This  is  achieved  by  supplying  sufficient 
amounts of fresh solvent to the solid interface by either removing dissolved solute from, or 
by  using  very  large  amounts  of  the  dissolution  medium.  Different  limits  have  been 
proposed for ensuring that sink conditions prevail. According to the USP sink conditions 
are achieved when the volume of dissolution medium is at least three times the volume 
needed  for  saturation  concentration  (USP  2001).  Another  proposed  limit  is  that  the 
concentration of dissolved substance does not exceed 10 % of saturation concentration, and 
yet another that the drug dissolves in less than 20-30% of available solvent (Mosharraf and 
Nystrom 1995; Amidon et al. 1995). 
4.2 The effect of pH
For ionizable compounds pH plays a significant role on solubility and the dissolution rate 
through  the  extent  of  dissociation  (Bhattachar  et  al.  2006).  Since  most  pharmaceutical 
compounds are weak electrolytes, the pH of the solution and pKa of the dissolving drug 
substance  should  always  be  assessed  when  determining  solubility.  The  pH  dependent 
solubility of monoprotic weak acids and bases can be expressed with modified Henderson-
Hasselbalch equations, which for acids takes the form,
SpH = S0(1 + 10(pH - pKa))                                             (21)
and for bases is expressed as,
SpH = S0(1 + 10(pKa - pH))                                              (22)
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where SpH is the solubility at a certain pH and S0 is the intrinsic solubility of the compound. 
The equations point out that increasing the pH of the solution where a basic compound is 
dissolving will lead to decreased solubility of the compound (Figure 3). Regarding acids the 
case is reversed. In the case of dissolving salts, the dissociation of salt into ionized drug and 
counterion  is  also  an  equilibrium  phenomenon.  This  is  a  factor  to  be  taken  into 
consideration because of the common ion effect, where the solution has a concentration of 
ions  alike  the  counterion,  that  will  decrease  the  extent  of  dissociation  and  thus  the 
dissolution  rate  and  solubility.  In  the  GI  tract  this  effect  is  especially  meaningful  for 
hydrochloride salts. 
Figure 3. Dependency of the solubility on pH for a monoprotic base with pKa 5. The 
maximum solubility is achieved just below pH = pKa – 1(from Bhattachar et al. 2006). 
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4.3 Particle size, shape and agitation
Hydrodynamics and the intensity of agitation impact the dissolution rate through the effect 
of mixing (Hixson and Crowell 1931; Brünner and Tolloczko 1900). Mixing of the solution 
causes the stretching out of areas of high concentration, greatly increasing the contact area 
with regions of lower concentration and consequently leading to rapid equilibration of the 
concentration (Hixson and Crowell 1931). Additionally agitation affects the dissolution rate 
by decreasing the diffusion layer thickness, which is also affected by the particle shape and 
size of the dissolving substance (Wurster and Taylor 1965; Galli 2006). Irregular particle 
shapes have been shown to cause an increase in the diffusion layer thickness (Mosharraf 
and Nyström 1995). Thus, when studying irregular particles, a shape factor, which increases 
with increasing deviation from sphericity,  is  often considered in the calculations.  Since 
dissolution  rate  is  directly  proportional  to  surface  area  of  the  dissolving  compound, 
reducing the particle size is often the first approach for increasing the dissolution rate of 
poorly soluble  compounds (Amidon et  al.  1995;  Wang and Flanagan 1999;  Hörter  and 
Dressman 2000).  Effects of particle size on the dissolution rate have been predicted to be 
significant at particle sizes below 200 µm (Amidon et al. 1995; Wang and Flanagan 1999). 
For  particles  above  50  μm  it  has  been  shown  that  the  diffusional  dissolution  rate  is 
inversely  proportional  to  the  particles  diameter  (Galli  2006).  On  the  other  hand,  for 
particles below 50 μm the dissolution rates are higher than what the inverse proportionality 
would infer. This discrepancy is explained by the changing diffusion layer thickness. For 
particle  sizes  above  50  μm  the  diffusion  layer  thickness  has  been  determined  to  bee 
constant at  roughly 30  μm (Hintz and Johnson 1989). The diffusion layer thickness for 
particles below 50 μm however changes with, and is approximately equal to particle radius 
or diameter. As this shift occurs the dissolution rate becomes inversely proportional to the 
square of the particle diameter (Galli 2006).  
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Smaller particles, on the other hand, also have larger surface energies, due to the increased 
surface  curvature  of  these  particles  (Wang  and  Flanagan  1999).  This  increases  the 
probability of particle aggregation and agglomeration, which in turn decreases the effective 
surface area available for dissolution  (Yu 1999).  This phenomenon can be counteracted 
with surface active agents, which will improve the wettability of particles and decrease the 
cohesive  forces  that  lead  to  aggregation  and  agglomeration  (de  Villiers  1996).  When 
dissolving powders the mean effective surface area will accordingly be dependent on the 
particle  size  distribution  and  on  the  extent  of  aggregation  and  agglomeration  of  the 
particles.  The dependency of dissolution rate on surface curvature can be derived from 
Fick's I law of diffusion and is expressed as follows,
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where  r  is  the radius of curvature,  which for a spherical  particle is equal to the radius 
(Wang and Flanagan 1999). The dependency of solubility on the particle size is given by 
the Ostwald-Freundlich equation,
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where Sr is the solubility of a particle of radius, r, S0  is the solubility of a relatively large 
particle, γ is the surface tension and V the molar volume of the small particle, R is the gas 
constant and  T the temperature (Martin et al. 2011). The particle size effect on intrinsic 
solubility is  however  only seen for  average  particle  sizes  below 0.1  μm (Florence  and 
Attwood 2011). 
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4.4 Solid state properties
Another property with great impact on solubility and dissolution rate is the solid state, i.e.  
different polymorphs, amorphous, (co-)crystal, solvate and salt forms of the drug (Huang 
and Tong 2004). Especially the dissolution rate and apparent solubility can be enhanced 
through  chemical  structure,  salt  and  solid  form  modifications,  and  salt  formation  is 
considered to be one of the main routes to improved bioavailability (Huang and Tong 2004; 
Sugano et al.  2007). The effect on dissolution rate and solubility of different solid state 
modifications is explained by the different lattice energies of the different forms (Huang 
and Tong 2004). The apparent solubility is affected by these properties, since the higher 
energetic solid forms often induce supersaturation, which in vivo results in higher intestinal 
concentrations of drug substance and consequently in higher bioavailability (Takano et al. 
2012). The time which the drug resides in the GI tract,  i.e. the so called mean intestinal 
transit time (MITT) is also a factor to be taken into consideration, since the drug has to 
dissolve in this timeframe (one to three hours) in order to be absorbed (Dressman et al. 
1998). It has accordingly been shown that if the drug does dissolve inside this timeframe 
and significant recrystallization does not occur, supersaturation, instead of solubility, can be 
used as the absorption predicting factor (Takano et al. 2012). The difference in solubility 
between different  polymorphs and hydrate/anhydrate  forms of  the same drug substance 
have  been  found  to  generally  differ  twofold  or  less,  while  the  difference  in  solubility 
between  amorphous  and  crystalline  material  is  more  diverse  and  can  show  up  to 
hundredfold differences (Huang and Tong 2004; Pudipeddi and Serajuddin 2005). The large 
difference in the solubility of amorphous and crystalline solids can be understood through 
the Yalkowsky General Solubility Equation (Equation 20), since the dissolution process of 
amorphous materials do not include the step of overcoming crystal lattice energies.
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4.5 Gastrointestinal conditions
For ionizable compounds, pH changes along the intestinal tract will alter the solubility and 
dissolution rate during the transit (Amidon et al. 1995). Additionally the buffer capacity, 
ionic strength, and as mentioned before, the common ion effect impact the dissolution rate 
and  solubility  of  these  drugs  (Kerns  and  Di  2004;  Hörter  and  Dressman  2000).  The 
possibility of decomposition, micelle formation and complexation with GI contents,  e.g. 
other ions or bile  salts  can also lead to reduced activity of APIs (Amidon et  al.  1995; 
Dressman et al. 1998; Avdeef 2007). Therefore, it is of particular importance to determine 
the  site  specific  dissolution  rate  for  drugs  which  demonstrate  varying  solubility, 
permeability and stability along the gastrointestinal tract (Amidon et al.  1995). For low 
solubility drugs the solubilization effect, which in the GI-tract is mediated by amphiphilic 
surfactants such as bile salts, lecithin and monooleins, is significant with up to 100-fold 
increases in solubility (Hörter and Dressman 2000). An additional factor is the viscosity of 
the GI contents, which affects the dissolution rate through the effect on diffusion.
The gastrointestinal environment for dissolution varies in pH, enzymes, surfactant, lipid 
and liquid  content  depending on  the  fasted  or  fed  state,  and  also as  a  consequence  of 
disease-induced changes (Amidon et al.  1995; McConnell et al. 2008). Additionally, the 
different states show variation in the cyclical motility of the intestines, intestinal  transit 
times and gastric emptying, which in turn affect the hydrodynamics and time available for 
dissolution. In fact, during the course of transit of a drug in the intestines, all the factors of 
the extended Noyes-Whitney equation (Equation 4) may change, i.e. the surface area of the 
particles,  the  diffusion  coefficient,  solvent  volume,  the  diffusion  layer  thickness, 
equilibrium solubility and concentration of dissolved substance (Table 1) (Macheras and 
Dokoumetzidis 2000). It can thus be seen why predicting drug absorption in this complex 
biological environment might impose difficulties (Amidon et al. 1995).
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Table 1. The relationship between factors of the Noyes-Whitney equation and 
physicochemical and physiological parameters (adapted from Dressman et al. 1998)
Factors Physicochemical parameters Physiological parameters
Surface area (A) particle size, wettability surfactants in gastrointestinal fluids
Diffusion coefficient (D) molecular size viscosity of gastrointestinal fluids
Volume of solvent (V) secretions and coadministered fluids
Diffusion layer thickness 
(h) particle size
motility pattern, agitation 
and flow rate
Solubility (CS)
logP, crystal structure, 
solubilization
pH, buffer capacity, bile, 
food components
Concentration of dissolved 
substance (Ct)
permeability
4.6 Formulation and experimental setup
While physicochemical properties of the API are the core underlying factors determining a 
products overall dissolution rate and solubility, formulation modifications can be used to 
affect these properties (Sugano et al. 2007; Tong et al. 2009). Especially the dissolution rate 
can  be  affected  through  formulation  approaches.  The  formulation  can  however  also 
negatively impact in vivo dissolution, such as in cases where the drug is not released fast 
enough, or at the proper site for absorption in the GI tract (Dressman et al. 1998). 
In  addition  to  properties  of  the  solute  and  solvent,  also  the  experimental  setup  and 
apparatus  will  impact  the  results,  through the  influence  of  the  factors  discussed  above 
(Brünner and Tolloczko 1900). Sample preparation and analysis is also a factor to be taken 
into account. For example the capacity of the analytical method to distinguish between the 
analyzed  substance  and impurities,  or  the  reliability  of  the  calibration  curve  are  to  be 
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considered,  since  it  has  been  shown that  filters  may act  as  nonspecific  binders  of  the 
analyzable substance and that centrifugation can be insufficient in removing all suspended 
particles (Alsenz and Kansy 2007; Kerns et al. 2008). Especially in cases where an attempt 
to reflect  in vivo conditions with the  in vitro setup is made, the relevant factors are to be 
thoroughly assessed (Dressman et al. 1998). At the moment in vitro experimental setup and 
the pharmacopoeial apparatus for dissolution tests poorly reflect the in vivo conditions, and 
changes  in  both  test  equipment  and  media  have  been  proposed  (Hörter  and  Dressman 
2000). 
5 THE BIOPHARMACEUTICS CLASSIFICATION SYSTEM AND IN VITRO – IN 
VIVO CORRELATION
Oral absorption is controlled by three factors namely the dissolution rate, solubility and 
permeation of the intestinal membrane (Chen et al. 2006). The relation can be expressed by 
a membrane applied modification of Fick's I law,
J  = PC                                                     (25)
where J is the flux of drug substance through a point in the intestinal wall (mass/area/time), 
P is the permeability of the intestinal membrane and  C   the concentration of drug at the 
lumenal side of the intestine (Amidon et al. 1995). The lumenal concentration is of course a 
function  of  the  dissolution  rate.  From  this  equation  it  follows  that  the  driving  force 
determining the flux of drug to the blood is the concentration gradient across the intestinal 
membrane (Lipinski et al. 2000). For high solubility compounds, when fast dissolution rate 
is assumed, the rate of absorption is limited only by intestinal permeability.  If the drug 
dissolves faster than it is absorbed, solubility will be the limiting factor, and the maximum 
absorption rate, Jmax can be expressed as,
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SPCJ =
max                                                     (26)
(Amidon et al. 1995, Chen et al. 2006).
In vitro – in vivo correlation (IVIVC) is defined by the USP as a correlation between a 
biological response and a physicochemical property of the same dosage form (USP 2001). 
In the case of bioavailability the biological parameter is the plasma drug concentration and 
the in vitro physicochemical property is the dissolution rate (Okumu et al. 2008). In order to 
establish IVIVC of dissolution rate, the dissolution medium used in in vitro studies should 
reproduce  the  in  vivo gastro-intestinal  conditions,  with  pH,  surfactants,  volume etc.  as 
closely as possible (Amidon et al.  1995). Also physical factors such as particle size are 
important to be reflected in the actual in vivo case. Only in this way is it possible to assess 
the  in  vivo dissolution rate,  and  the  limitations  adhering  to  it,  with  sufficient  accuracy 
(Dressman et al. 1998). Since the USP only provides a simulated gastric fluid (SGF, with or 
without pepsin) and a general simulated intestinal fluid (SIF, with or without pancreatin), 
other biorelevant dissolution media simulating fasted and fed states have been developed 
(USP 2001;  Galia  et  al.  1998).  These  media,  i.e. fasted  state  simulated  intestinal  fluid 
(FaSSIF) and fed state simulated intestinal fluid (FeSSIF) more closely mimic the fasted 
and fed state contents of the proximal small intestine, including physiologically relevant 
concentrations of bile salts (Galia et al. 1998). Therefore they are much more applicable to 
IVIVC studies, and have been shown to be able to predict  in vivo data more accurately 
(Nicolaides et al. 1999). 
Amidon  and  coworkers  proposed  in  1994  the  Biopharmaceutics  Classification  System 
(BCS) in which drugs are divided into four categories, depending on their solubility and 
permeability  (Table  2)  (Amidon  et  al.1995).  The  classification  has  subsequently  been 
adopted by regulatory agencies (e.g. the U.S. Food and Drug Administration (FDA) 2000). 
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According to the FDA guidance on biowaivers, a drug product is considered to have high 
solubility  if  the  highest  dose  dissolves  in  250  ml  or  less  of  aqueous  media  within 
physiologically relevant pH 1.0-7.5 (FDA 2000). Likewise a drug product is considered 
highly  permeable  if  90%  or  more  of  the  administered  dose  is  absorbed,  and  rapid 
dissolution is assumed when 85% or more of the dose is dissolved within 30 minutes, using 
USP Apparatus  I  with instructed  biorelevant  media.  For  certain  compounds,  as  will  be 
discussed, with dissolution rate limited absorption, the bioavailability of a new or existing 
drug products can be assessed with biowaivers, i.e. in vitro dissolution tests that substitute 
in vivo clinical tests.
Table 2. The Biopharmaceutics Classification System (adapted from Amidon et al. 1995)
BCS class I
High solubility
High permeability
BCS class II
Low solubility
High permeability
BCS class III
High solubility
High permeability
BCS class IV
Low solubility
Low permeability
BCS class I drugs have high solubility and high permeability making the drug absorption 
dissolution rate or, in cases where the drug dissolves very fast, gastric emptying rate limited 
(Amidon et al.1995). In the case where dissolution rate is slower than gastric emptying, 
saturation  concentrations  or  maximum  permeability  are  not  reached  and  absorption  is 
dissolution rate limited. Consequently an IVIVC of absorption with dissolution rate can be 
expected, and the biowaiver dissolution test for immediate release (IR) products of this 
class only have to prove rapid release from the dosage form in aqueous media (Dressman et 
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al. 1998). 
BCS class II drugs have low solubility and high permeability (Amidon et al.1995). In this 
case   maximum permeability is  not  reached at  any point  and  thus  all  the  drug that  is 
dissolved  in  the  GI  tract  is  absorbed.  Consequently  the  absorption  rate  will  be  highly 
dependent on the dissolution rate of the drug, except for very high doses where saturation 
of GI fluids occurs and solubility becomes the rate limiting factor (Dressman et al. 1998). 
Accordingly, a strong IVIVC can be expected if the  in vivo GI conditions are adequately 
reflected in vitro (Amidon et al.1995; Dressman et al. 1998). BCS class III drugs have high 
solubility and low permeability (Amidon et al.1995). For this class the variation in drug 
absorption will be limited by the intestinal permeability, if the drug dissolves faster than the 
gastric emptying. Since the dissolution rate is not the absorption rate limiting factor, no or 
limited IVIVC is expected. However dissolution rate is relevant also for this class, since 
rapid dissolution increases the contact time with the intestinal wall,  which consequently 
increases the possibility of absorption (Dressman et al. 1998). BCS class IV drugs have 
both low solubility and low permeability and show general poor bioavailability (Amidon et 
al.1995; Dressman et al. 1998). Since the dissolution rate is not alone the limiting factor, it 
is not possible to establish IVIVC based solely on the dissolution rate.
It  can  be  seen  from  the  above  classification  that  dissolution  rate  and  solubility  play 
significant roles in the absorption and bioavailability of a drug product. Changing these 
factors also has a greater impact on the absorption than does changing the permeability 
(Lipinski et al. 2000). For a drug with low solubility and dissolution rate, increasing the 
permeability does not affect the absorption, since the amount of absorbable substance is not 
increased. Sub-par permeation, on the other hand, can be compensated by good solubility 
and dissolution rate, since a greater amount of compound is then available to be absorbed. 
The percentual distribution in the different BCS classes for new drug products between 
1995 and 2002 where BCS class I 14%, BCS class II 12%, BCS class III 28% and BCS 
class IV 46% (Stegemann et al. 2007). If absorption of BCS class III drugs are taken to be 
25
mainly permeation limited, it can be seen that for 72% of new products launched during 
this period, bioavailability was highly (BCS I & II) or partially (BCS III) dependent on 
dissolution rate and/or solubility. It can also be concluded that for BCS class I and II drugs 
with high permeability, sink conditions will prevail in the GI tract and the limiting factor 
will actually be the IDR of the substance.
It  has  been  proposed  that  the  IDR,  rather  than  solubility,  should  be  the  basis  of  the 
biopharmaceutical classification of drugs, since the kinetic nature of intrinsic dissolution 
might correlate better with in vivo drug dissolution (Yu et al. 2004). Contrary to solubility 
the IDR is also dependent on wettability and diffusivity of the dissolving substance (Zakeri-
Milani et al. 2009). Additional advantages of IDR studies over solubility studies are the 
lesser amounts of time and compound needed and the possibility of identifying solid form 
changes from acquired data (Yu et al. 2004). The suggested threshold for separating high 
and  low  solubility  compounds  is  1-2  mgcm-2min-1 (Zakeri-Milani  et  al.  2009).  IDR 
measurements could additionally be very usable in API salt and solid form selection since 
the particle size does not affect the result (Sugano et al. 2007).
6 DISSOLUTION APPARATUS
The history of the compendial dissolution apparatus began in 1962 when the committee of 
the  Pharmaceutical  Manufacturers  Association  brought  forth  the  idea  of  incorporating 
dissolution testing in the monographs of all solid dosage forms with less than 1% aqueous 
solubility (Cohen et al. 1990). Up until then, disintegration tests had been the general way 
for testing solid dosage forms, but the promotion of dissolution tests  was based on the 
increased understanding of the relevance of dissolution phenomena for the bioavailability 
of drugs. In the beginning development was slow, but gradually the standardization and 
incorporation  of  dissolution  tests  advanced,  culminating  in  the  late  1980's  when  all 
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monographs for conventional dosage forms had been evaluated, and dissolution tests had 
been developed for the relevant compounds. 
Today  the  United  States  and  European  Pharmacopoeias  list  four  main  apparatus  for 
dissolution tests, all of which ought to be partially submerged in water baths of 37 ± 0.5 °C 
during the tests (European Pharmacopoeia (Ph.Eur.) 2013a; USP 2001). The first apparatus, 
generally called USP apparatus I or basket apparatus (Figure 4), was adopted by the USP in 
1968 (Cohen et al. 1990). It consists of a transparent 1 liter, round bottomed dissolution 
vessel and a cylindrical stainless steel mesh basket connected to a rotating motor by a drive 
shaft (Ph.Eur. 2013a; USP 2001). During tests the basket, with sample, is rotated at constant 
speed, 25 ± 0.2 mm above the bottom of the vessel. USP apparatus II or paddle apparatus 
(Figure 4), together with USP apparatus I are the two most used apparatus for dissolution 
tests of solid dosage forms. The apparatus was adopted in 1978 and is identical with USP 
apparatus I, except that the basket is exchanged for a paddle, and the studied sample is kept 
at the bottom of the dissolution vessel during tests (Cohen et al. 1990; Ph.Eur. 2013a; USP 
2001). Both USP apparatus I and USP apparatus II generally use 900 ml of dissolution 
medium for each test. 
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Figure 4. Schematic representation of the USP I basket apparatus (left) and the USP II 
paddle apparatus (right) (modified from Ph.Eur. 2013a).
The USP apparatus III or reciprocating cylinder is different entirely and is more rarely used 
(Ph.Eur. 2013a; USP 2001). It consists of outer and inner flat bottomed glass cylinders. The 
sample  is  put  inside  the  inner  glass  cylinder,  which  is  then  sealed  and  vertically 
reciprocated, by a motor, inside the outer cylinder. The fourth apparatus is the flow-through 
cell or USP apparatus IV. It has a vertical setup, where the cell of inert transparent material 
has a cone-like lower part. The dissolution medium flows upward through the cone, which 
is usually filled with glass beads to allow a more even flow, and the sample is put inside the 
cell  between  the  glass  beads  and  an  upper  filter.  The  aim  of  the  filter  is  to  prevent 
undissolved particles from escaping.  Standard flow-rates  used are 4,  8,  and 16 ml/min. 
Several non-compendial modifications of the flow-through cell also exist and it is a general 
denomination for dissolution methods that use pumps to provide a liquid flow across the 
sample. Sink conditions are maintained with open system set-ups, where fresh medium is 
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continuously provided  to  the  sample  surface.  Recent  flow-through measurements  using 
biorelevant pH gradient changes, reflecting the GI tract passage of an oral dosage form, 
have been successful in assessing whole in vitro profiles and establish IVIVC (Okumu et al. 
2008).
The intrinsic dissolution rate is traditionally measured by a modified USP apparatus II, with 
an  additional  pellet  holder  (Hulse  et  al.  2012).  The  apparatus  is  also  called  Wood's 
apparatus and the results disc intrinsic dissolution rates (disc-IDR). First a compacted pellet 
with a diameter of 0.1-1.0 cm is produced with a tablet press using a die and punch (USP 
2001). The pellet, with a specific surface area exposed in the die is then mounted on the 
stirrer and rotated in the dissolution medium. Yu (2004) and coworkers  showed in their 
studies that disc compression force, solvent volume and disc position do not have a notable 
effect  on measured IDRs, as long as the compressed disc  did not fall  apart  during the 
experiment.  All  these  so  called  ”compendial”  dissolution  methods  have  become  an 
established way to assess dissolution rates. However questions have been raised regarding 
their suitability in reflecting  in vivo  conditions (Dressman et al. 1998).  For example, the 
hydrodynamics of the paddle and basket apparatus in relation to GI conditions have come 
under  scrutiny.  Other  problems  also  exist,  such  as  the  settling  of  a  disintegrated  drug 
product at the bottom of a dissolution vessel, which can have a significant impact on the in  
vitro dissolution  rate  and  thus  not  reflect  in  vivo conditions  accurately  (FDA 2000). 
Moreover, the flow rates of the small intestine range from 0-7 ml/min in the fasted and fed 
states, in light of which the USP flow-through apparatus flow rates of 8 or 16 ml/min can 
be  considered  high  (Kerlin  et  al.  1982;  Dressman  et  al.  1998).  Additionally  the  one 
directional  flow pattern  that  leads  to  non-equal  dissolution  from different  faces  of  the 
compound, does not represent the mixing patterns of the intestines (Dressman et al. 1998).
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7 DISSOLUTION TESTING IN DRUG DEVELOPMENT
After the introduction of dissolution testing of solid dosage forms in the 1960's, dissolution 
testing has become a widely used tool in many areas of the pharmaceutical development 
process. In drug development, dissolution assessment is used in the registration process, as 
a screen of API properties, guidance for formulation design, a way to assess time dependent 
drug release and as a quality-control and bioequivalence screening tool (Tong et al. 2009). 
Due to the large amount of new chemical entities (NCEs) being poorly soluble BCS class II 
or class IV compounds, the assessment of the dissolution rate of NCEs is gaining increased 
attention (Hulse et al. 2012). It can thus be seen that as the appreciation of the relevance of 
dissolution  data  grows  and  the  analytical  techniques  evolve  to  accommodate  to  their 
broader usage, dissolution testing is being adopted ever earlier in the drug development 
pipeline (Figure 5).
Figure 5.  Current state of solubility and dissolution testing in drug discovery and early 
development (modified from Sugano et al. 2007)
7.1 Phase III
During  phase  III,  in  vitro  dissolution  testing  is  used  to  characterize  drug-product 
performance (Tong et al. 2009). Dissolution testing, or surrogate tests established through 
the understanding of the critical parameters affecting the dissolution rate, may also be used 
to evaluate quality attributes and process parameters affecting product performance. These 
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product performance controls ensure that the process is kept inside the design space and, 
consequently,  assures  the  products'  clinical  performance.  The  in  vitro determination  of 
similarity of dissolution profiles after formulation and process changes, is also to a large 
extent sufficient, even in certain cases when the product lacks IVIVC, to replace  in vivo 
bioequivalence studies.
7.2 Phase II & I
During Phase II a finalized formulation is usually developed and the development effects 
on  the  dissolution  rate  should  be  continuously  monitored  (Tong  et  al.  2009).  Through 
understanding of the critical factors affecting the dissolution of a specific product, surrogate 
tests, such as disintegration or API property characterization, can be developed to monitor 
product consistency. This is an example of the so called quality by design (QbD) approach 
in drug development, which is being increasingly applied in the pharmaceutical industry 
today.  Bach release  and batch-to-batch  consistency in  addition  to  product  stability  and 
IVIVC are the parameters being evaluated.  During Phase I  the emphasis  of dissolution 
testing is on establishing an IVIVC or in vitro - in vivo relationship (IVIVR) for the primary 
formulation and biorelevant media of different pH are used to screen dissolution profiles, 
especially in cases where extended release formulations are attempted. 
7.3 Early development
Dissolution  profiles  are  currently  assessed,  and  are  in  a  central  position  in  later  drug 
discovery and early development, when screening for a compound’s most optimal salt-, 
polymorph- and (co-)crystal forms (Figure 5) (Curatolo 1998; Sugano et al. 2007). In this 
phase the amount of substance available is on the 100 mg scale (Sugano et al. 2007). In 
early development dissolution rate studies of API salt and solid forms are conducted in 
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order  to  establish  the  BCS  classification,  and  to  later  enable  the  establishing  of  a 
quantitative  structure  property  relationship  (QSPR)  between  API  properties  and 
pharmacokinetic (PK) data (Tong et al. 2009). Early development dissolution screening is 
also used as an aid in  primary formulation selection for animal  toxicology studies and 
Phase I clinical studies. Additionally, adequate bioavailability has to be established in order 
to enable the determination of metabolic and pharmacological properties, side effects and 
the preliminary efficacy of a substance through in vivo tests. 
8 DISSOLUTION TESTING IN DRUG DISCOVERY
In the beginning of the 1990's, high-throughput screening (HTS) of new drug compounds 
became widely used as an effective method for finding lead compounds with enhanced in  
vitro pharmacological potency (Kubinyi 1995). The advent of combinatorial chemistry also 
allowed an unprecedented amount of compounds to be automatically synthesized and to be 
available  for  discovery  scientists.  However,  this  departure  from  traditional  screening 
methods unintendedly led to inferior physicochemical profiles of new compounds and poor 
solubility became an industry-wide problem (Curatolo 1998; Lipinski et al. 2000; Sugano et 
al.  2007).  Simultaneously  research  and  development  (R&D)  spending  has  continually 
increased in the pharmaceutical industry, while the rate of entry of new drug products to the 
marketplace has not grown accordingly (Table 3) (Venkatesh and Lipper 2000). The output 
of  NCEs  has  actually  decreased  significantly  and  one  of  the  reasons  is  that  potent 
substances show, as a result of HTS and 'rational drug designing', higher molecular weight 
(MW >500 Da) and lipophilicity (logP >5) (Curatolo 1998; Lipinski et al. 2000; Gardner et 
al. 2004). As postulated by the Lipinski 'rule of 5', which states that the permeability and 
absorption of a compound is decreased if the compound expresses more than one of the 
following properties: over 5 H-bond donors, more than 10 H-bond acceptors, MW over 500 
daltons  (Da)  or  logP  over  5,  the  higher  MW  and  lipophilicity  tend  to  decrease  the 
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substances  solubility  and permeability,  leading  to  increased  development  time and cost 
(Lipinski et al. 2000; Gardner et al. 2004). As stated by Curatolo (1998): ”An efficacious 
but non-absorbed agent is no better than a well-absorbed but inefficacious one”.
Table 3. Relationship between Pharmaceutical Industry R&D spending and NCE output 
(Venkatesh and Lipper 2000)
Output measure per company 1991-1995 1996-2000 Change
NCE output 12.3 7.2 -41% 
R&D spending (billion US $) 5.9 8.5 +44 %
This  problem  has  consequently  been  taken  into  consideration  and  modern  candidate 
selection is   becoming increasingly based on a  more  holistic  consideration of  potency, 
pharmacological,  toxicological  data  and  physical  properties  in  addition  to  production 
suitability  calculations  (Figure  6)  (Gardner  et  al.  2004;  Sugano  et  al.  2007).  Common 
physicochemical  properties  that  are  routinely  profiled  during  discovery  to  assess  the 
absorption potential of a NCE include solubility permeability, lipophilicity, pKa, integrity 
and stability (Kerns 2001; Takano et al. 2012). All of these factors play an important role in 
subsequent  decision  making  regarding  developability,  lead  optimization,  optimal 
formulation choice and risk assessment (Huang and Tong 2004). However, to be able to 
make accurate decisions the quality of the underlying data has to be sufficient. The lack of 
adequate technological approaches to assess these properties at an early stage has therefore 
imposed limitations (Gardner et al. 2004).
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Figure 6. A more holistic view for drug candidate selection (Kerns 2001).
Poor  solubility  and dissolution  rate  can  be,  as  previously discussed,  improved  through 
choosing an appropriate  formulation  (Lipinski  et  al.  2000).  Advanced formulations  can 
however result in increased risk, costs and delays and it has been estimated that a delay of 
entrance to the marketplace of a new important drug product can result in revenue losses of 
up to 1 million dollars per day (Kerns 2001). Therefore, the possibility of early assessment 
of drug solubility and dissolution rate in the discovery and development phases would be 
highly beneficial. This early characterization would allow modifications to be made to the 
API's  chemical  structure,  which  has  been  suggested  to  be  the  main  way of  correcting 
inadequate solubility of a compound and is only done during the discovery stage (Sugano et 
al. 2007). The problem of inadequate early physical characterization of a lead candidate is 
emphasized by the fact that these problems usually surface at a development stage, where 
optimization of other candidate properties are already at an advanced stage (Gardner et al. 
2004). The possibility of early evaluation of physicochemical data would therefore narrow 
34
the  risk  of  downstream  ADMET  (absorption,  distribution,  metabolism,  elimination, 
toxicity) problems and consequently reduce development delays (Kerns 2001). 
The solid form of a compound has not necessarily been chosen at the discovery stage and 
variation  in  crystal  forms  are  common  (Kerns  2001;  Sugano  et  al.  2007).  The  main 
challenge at these early stages is also to produce compounds of sufficient purity,  and a 
degree of purity above 95% is regarded to be necessary in order to allow the acquisition of 
high  quality  data  in  line  with  non-miniaturized  methods  (Balbach  and  Korn  2004). 
However,  the  variation  in  crystal  form  does  not  necessarily  impose  a  significant 
misinterpretation of the general solubility and dissolution profile, since it has been shown 
that the solubility ratios between pharmaceutical polymorphs are on the scale of twofold or 
less (Pudipeddi and Serajuddin 2004). 
At these early stages dissolution methods are rare and solubility is the main factor being 
studied  (Figure  5).  Large  amounts  of  compounds  are  also  screened  for  qualitative 
physicochemical characteristics by in silico computational methods (Curatolo 1998). These 
widely used in silico modeling methods are used due to the lack of sufficient amounts (less 
than a few milligrams) of compounds for physical in vitro screening (Lipinski et al. 2000; 
Sugano  et  al.  2007).  Computational  methods  are  however  based  on  theories  and 
assumptions and are thus inherently lacking in accuracy (Sugano et al. 2007). Especially 
properties such as solubility and dissolution rate are difficult to predict, since the equations 
and assumptions related to these properties are built upon many other factors which are also 
difficult to predict, such as crystal lattice energies and pKa. This, in combination with the 
uncertainty regarding the properties of NCEs can result in above 10-fold  prediction errors. 
In silico models therefore need high quality input parameters from and validation through 
real experimental data. 
HTS solubility methods commonly used in the industry today are based on the assessment 
of kinetic solubility (Kerns 2001). Common analytical techniques for the quantification of 
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solubility data include turbidimetric approaches where light scattering is used to measure 
dissolved  or  precipitated  substance,  UV  plate  readers,  high-performance  liquid 
chromatography (HPLC) and  mass spectrometry coupled liquid chromatography (LC/MS). 
Kinetic solubility can however be significantly higher than equilibrium solubility due the 
presence of DMSO in the solution, the short incubation times and solid state effects (Kerns 
2001; Sugano et al. 2007). Moreover, the act of predissolving in DMSO obviously masks 
the influence of crystal lattice energies and polymorphic forms, on solubility, and the data is 
not applicable for QSPR assessment (Huang and Tong 2004; Lipinski et al.  2000). The 
inherent problems in kinetic solubility measurements have led to a shift towards small-scale 
thermodynamic solubility studies, in order to produce early, higher quality solubility data 
for compound ranking and selection (Alsenz and Kansy 2007). However, as the incubation 
times needed for accurate assessment of thermodynamic solubility data, range from several 
hours to days, it is therefore not as applicable as the kinetic solubility assay for large-scale 
screening.
9 MINIATURIZATION OF DISSOLUTION METHODS
As  has  been  made  evident  throughout  this  text,  dissolution  rate  studies  could  have  a 
significant  advantage  over  solubility  studies  in  drug  discovery.  First  of  all  dissolution 
studies  require  substantially  less  time  and  substance  for  the  single  experiments.  When 
carrying out equilibrium solubility measurements, an excess amount of solid substance has 
to be in contact with the saturated medium over long periods of time (Sugano et al. 2007). 
In cases when equilibrium is not immediately achieved after the first incubation, several 
more  additions  of  substance  may  be  required.  However  in  dissolution  studies,  where 
saturation is not strived after, accurate data can be collected from the primary experiments, 
and from as small amounts of drug compound as the analytical method allows. Especially 
IDR data could be rapidly acquired since only data from the first 10% of the dissolution 
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curve is usually required (USP 2001). Regarding kinetic solubility studies, in which the 
timescale  and  compound  consumption  is  reduced,  the  accuracy  of  the  results  is 
questionable  and not  directly interchangeable with equilibrium solubility (Sugano et  al. 
2007).  Moreover,  dissolution  rates  cannot  be  accurately  predicted  from  equilibrium 
solubility, but the solubility can be predicted from dissolution rates and IDRs.  
As has been previously discussed, the kinetic property of dissolution could reflect  in vivo 
events more accurately, since the dissolution data includes both the initial wetting stage and 
the impact of diffusion. Additionally the dissolution rate incorporates the effect of particle 
size  and  physical,  solid  state  properties  into  the  data,  none  of  which  are  reflected  in 
solubility data. Chemical properties on the other hand are reflected in both dissolution rate 
and solubility data. Accordingly, early dissolution experiments would allow the screening 
of  salt  and  solid  form dependent  dissolution  rates,  allowing  early  QSPR  assessments. 
Furthermore, as has been shown, solubility can be exchanged for IDR data in determining 
the BCS classification (Yu et al. 2004). If IDR data could be collected at these early stages, 
this would mean that formulation and development scientists could have access to reliable 
primary biopharmaceutical classification from the very first batches of a NCE. This could 
greatly  advance  the  initiation  of  their  participation  in  the  development  process,  and 
subsequently reduce development times. The possibility of using physiologically relevant 
conditions such as agitation,  flow rates,  pH and biorelevant  media,  in  i.e.  miniaturized 
flow-through apparatus, would also allow the acquisition of high quality  in vivo relevant 
input parameters for early in silico modeling. 
In spite of the considerable advantage of dissolution tests over solubility tests, regarding the 
amount and the accuracy of the data possible to collect from single experiments, mini-scale 
dissolution  tests  for  drug  discovery are  few.  The  reason for  this  might  be  the  lack  of 
appropriate technological approaches for studying dissolution at a small scale (Gardner et 
al. 2004). The current aim of method development for physicochemical characterization is, 
however, in earlier characterization and further reduction of the amount of time, compound 
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and cost,  and thus there lies a great potential in developing new small-scale dissolution 
methods  (Alsenz  and  Kansy  2007).  Especially  miniaturized  experiments  for  intrinsic 
dissolution could be suited for drug discovery and early development (Alsenz and Kansy 
2007; Sugano et al. 2007). Also, the prospect of intellectually protecting polymorphic forms 
gives  an  additional  incentive  to  develop  higher  throughput  methods  for  characterizing 
dissolution profiles at the early stages (Alsenz and Kansy 2007). 
Compendial  dissolution  apparatus  require  liquid  volumes  of  500  or  900  ml  and  API 
amounts from 100 to 700 mg and are therefore not applicable to drug discovery (Avdeef 
2007). The small amounts of available compound to be used  in these early experiments can 
also result in very low concentrations, preventing the quantification of dissolved substance, 
or at  least  leading to  the use of additional analysis  such as HPLC (Hulse et  al.  2012). 
Obviously all additional and non-common analytical techniques will increase the workload 
and  cost.  During  drug  discovery,  the  aim  is  usually  to  downscale  physicochemical 
characterization  measurements  to  the  96-well  plate  size  (Kerns  2001).  However,  most 
attempts for the miniaturization of dissolution tests have focused on the miniaturization of 
compendial  apparatus  for  early  development  (Emmanuel  et  al.  2010).  These  so  called 
”mini-paddle”  (Figure  7)  and  ”mini-basket”  apparatus  have  the  objective  of  producing 
similarity of  compendial conditions, e.g. hydrodynamics, which is understandable since the 
aim is to produce results for primary formulations that will be in line with future ”normal 
scale” results. 
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Figure 7. A mini-paddle apparatus with a 100 ml dissolution vessel (Christ 2009).
The miniaturized compendial methods are not however required for early characterization 
of NCE dissolution rates, and will certainly not be the best approach in developing new 
mini-scale dissolution tests. The aim of new small-scale tests is to produce as much high-
quality data as possible, at sufficient throughput rates (Balbach and Korn 2004). Moreover, 
when  developing  new  dissolution  methods  the  accuracy,  sensitivity,  specificity  and 
reproducibility of large scale equipment are to be maintained (Christ 2009). One approach 
through which it has been proven that it is possible to acquire high quality physicochemical 
data  from  small  amounts  of  pure  drug  substance  is  the  Aventis  ”100  mg-approach” 
(Balbach and Korn 2004). The success of the approach is demonstrated by the fact that, 
since its introduction, physicochemical issues have not been the cause behind any candidate 
failure. For early screening of dissolution rates of different salt and polymorph forms, this 
approach uses a miniaturized flow through cell. The method requires approximately 1.5 mg 
of drug powder per sample and uses HPLC as analytical technique. 
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There are also some commercially available mini-scale dissolution tests that require only 
milliliter volumes and analyze the samples by in situ fiber-optic probes (Christ 2009). One 
example is  the  μdiss method,  which uses 2 ml  of  dissolution media and 10-100  μg of 
compound  per  sample  (Avdeef  2007).  The  method  has  been  successful  in  predicting 
solubilities. A miniaturized IDR experiment was developed by Hulse et al. (2012). In their 
experiments, compressed discs of 3-10 mg of substance with a diameter of 2mm, were 
fixed at the bottom of a flow through apparatus and characterized by UV area imaging. A 
similarity was found with disc-IDR results from literature. IDRs comparable to results from 
standard disc-IDR measurements have also been obtained from powder samples as small as 
0.06 mg using in situ fiber-optic UV analysis (Tsinman et al. 2009). 
10 THE SINGLE PARTICLE APPROACH
The general way of studying dissolution rates, in both pharmaceutical and other sciences 
concerned with dissolution phenomena,  have thus far  been through the multiparticulate 
bulk  approach  (Marabi  et  al.  2008).  However,  one  of  the  great  disadvantages  of  this 
approach lies in the lack of understanding, and thus in the difficulty of modeling powder 
dissolution (Hulse et  al.  2012).  Important  factors  affecting  the dissolution  rate  of  solid 
substances  such  as  particle  size  distributions,  shape  distributions  and  the  degree  of 
aggregation and agglomeration, as well as the time-dependent change in these, are difficult 
to measure accurately (Avdeef et al.  2009). Moreover, in the case of mini-scale powder 
dissolution  methods,  only  rough  estimations  by  in  silico  methods,  requiring  many 
assumptions,  are  possible.  Thus,  the  single  particle  approach could  be  a  more  suitable 
approach.
While,  according  to  Aristotle:  ”the  whole  is  greater  than  the  sum of  its  parts”,  it  can 
nevertheless be argued that the whole is determined by its individual parts. This is also the 
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case with powders and powder dissolution, where the single particles composing the bulk 
powder  are  the  main  determinants  of  the  overall  bulk  properties  (de  Villiers  1996). 
Studying dissolution on the single particle level will thus produce in depth understanding of 
individual particle dissolution kinetics and, consequently,  important information about the 
dissolution kinetics of pure substances (Marabi et al. 2008). By analyzing dissolution with 
the single particle approach, the cohesive interactions between particles can be ignored and 
the particle shape and size may be exactly observed.  The single particle approach thus 
minimizes the assumptions regarding the factors influencing the dissolution rate, and the 
data can therefore be regarded as more accurate. Additionally, knowing the exact particle 
size and shape  allows a  direct  correlation between these factors  and the dissolution or 
intrinsic dissolution rate. This in turn allows the extrapolation of the acquired data to any 
particle shape(distributions), size(distributions) or effective surface areas. 
Thus far the single particle approach has been implemented only in a few cases, mainly in 
chemical  engineering  as  compiled  by Marabi  et  al.  (2008),  but  lately  also in  the  food 
(Börjesson et al. 2013) and pharmaceutical sciences (Prasad et al. 2002; Raghavad et al. 
2002;  Østergaard et al. 2011).  Prasad et al. (2002) investigated the dissolution rate from 
different faces of fixed single paracetamol crystals with optical microscopy. They found 
that different faces showed variation in surface topography and also significant differences 
in  the  dissolution  rates.  The  varying  dissolution  rates  of  the  different  faces  lead  to 
anisotropic dissolution of the crystals. Additionally they found that edges and corners had a 
preferential dissolution, leading to the rounding off of these areas. Similar results have also 
been  reported  for  single  crystals  of  α-lactose  monohydrate  by  an  almost  identical  test 
(Raghavan et al. 2002). Østergaard (2011) and coworkers studied the dissolution of single 
lidocaine crystals in a stagnant liquid. The crystals were mounted into holes drilled in the 
dissolution cell and analyzed by UV area imaging. They found that it was possible to apply 
this analytical method to dissolution studies of single particles. Their results also showed a 
decrease in dissolution rate for smaller crystals, which was assumed to be caused by the 
smaller surface area. 
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The spherical form of particles is a general assumption when modeling powder dissolution 
since the geometry is simple and easy to model (Marabi et al. 2008). The sphere is also the 
geometrical form with the lowest surface area per volume ratio, and thus with the lowest 
surface energy. It is therefore expected that the spherical shape is the most geometrically 
stable and, accordingly, the shape which will dissolve most isotropically. One of the early 
studies with single spherical particles was conducted by Parrot et al. in 1955. They studied 
the dissolution rate of single 1.27 cm compressed spheres of  pure drug substances in 2000 
ml volumes of agitated liquid. The dissolution rate was calculated from radius and weight 
measurements, as well as by titration. They concluded that the spherical particle shape was 
maintained throughout the experiment and that dissolution rates calculated based on the 
radius did not significantly differ from chemical analysis results. They also found that the 
dissolution rate was practically independent of density and directly proportional to weight 
and surface area. 
Marabi et al. (2008) studied the dissolution of single spherical sucrose particles in stagnant 
liquids. Through image analysis of micrographs they were able to measure the dissolution 
rates of the single spheres. They also used a mathematical shrinking sphere model to derive 
a  dissolution  rate  constant  and  to  correlate  this  rate  constant  with  the  viscosity  of  the 
different  dissolution  media.  Additionally  they  also  found  that  the  particle  retained  the 
spherical  shape  throughout  the  experiment.  Börjesson  et  al.  (2013)  also  used  optical 
microscopy to measure the dissolution rates of single sodium caseinate powder particles, in 
a custom made flow through cell. They fixed the spray dried powder particles by squeezing 
them between two glass slides and assumed a cylindrical shape in their calculations. In their 
density measurements they observed a large difference in intraparticle porosity, which was 
assumed to cause the difference in dissolution rates between particles. They also found a 
similarity  between  particle  and  time  averaged,  surface  specific  dissolution  rates  of  the 
particles and disc-IDR measurements. 
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11 OPTICAL MICROSCOPY AS ANALYTICAL TECHNIQUE
It can be concluded based on the literature, that in the few single particle dissolution studies 
that have been made, optical microscopy has been the most used analytical method (Prasad 
et al. 2002; Raghavad et al. 2002; Marabi et al. 2008; Börjesson et al. 2013). This is a novel 
application for optical microscopy as an analytical technique, which has been enabled by 
recent  advances  in  computing,  imaging  technologies  and  image  analysis  software 
(Almeida-Prieto et al. 2006). The fast development in digital imaging has also made digital 
microscopy  a  viable  analytical  tool  for  the  acquisition  of  high  quality  morphological 
particle data.
Optical light microscopy is generally used to study particles in the size range of 3 μm – 150 
μm, with the theoretical  minimum resolution being 0.2 μm (Allen 1997).  However,  the 
smaller the analyzed particle, the greater the ring of diffracted light around the particle will 
be,  with  respect  to  the  particle  size.  Accordingly  the  overestimation  of  particle  size 
increases with decreasing particle size, and it becomes significant at particle sizes below 3 
μm. Because of this effect, 0,8 μm is considered to be a realistic threshold for particle size 
analysis. Another limitation of the optical microscope is the shallow depth of focus. This 
means that areas of large particles, or of multiparticulate samples with a large difference in 
particle size, cannot be brought into focus in the same image. In the case of single particles, 
the shallow depth of focus means that the particle either has to stay or be fixed at a specific 
distance from the lens.
Despite these limitations, the advantages of studying dissolution through physical analysis, 
instead of chemical analysis, are many.  Common chemical analysis techniques such as UV-
spectrometry  and  HPLC  need  chemical  calibration  in  order  to  identify  the  dissolved 
substance. Particle size analysis of micrographs, on the other hand, does not require any 
chemical calibration and is therefore highly applicable to the analysis of NCEs, for which 
compound  properties  are  relatively  unknown  and  the  available  amounts  scarce. 
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Additionally, the visual area analysis of a dissolving particle provides more accurate data 
than  in situ analytical techniques that measure the concentration at a certain point in the 
medium. This  is  because the concentration  will  be unevenly distributed  throughout  the 
dissolution medium, with areas of higher and lower concentration, and the positioning of 
the analytical probe will therefore be a  source of error. Furthermore, image analysis does 
not  require  any  liquid  sample  collecting  or  preparation,  both  of  which  are  possible 
additional  sources  of  error,  and  therefore  have  to  be  validated.  Moreover,  the  more 
preparation steps  that  are  needed between sample  collection  and the  final  analysis,  the 
higher the risk of sample loss. The accuracy and discriminatory capabilities of chemical 
analysis methods are also greatly reduced when using more complex dissolution media i.e.  
biorelevant  media,  making it  difficult  to  distinguish the  analyzed  substance  from other 
dissolved substances or impurities. Lastly, the simplicity of digital image acquisition and 
computational image analysis makes this a fast analytical technique, highly applicable for 
automation and real-time data analysis. 
11.1 Image analysis
A digital image is composed of multiple squares called picture elements or pixels (Sandler 
2011). In order to analyze and process the images, they are usually converted into grayscale 
(monochrome) images (Sandler 2011; Allen 1997). The pixels of monochrome images are 
represented by a numerical value between 0 and 255. This value determines the grayscale 
shade, depending on the brightness and hue of the individual pixels, where 0 represents a 
black pixel and 255 a white pixel (Allen 1997). To enable the analysis of particle properties 
the monochromatic  image is  further  processed,  by  i.e. removing background noise and 
converting the monochromatic image into a black and white image, through thresholding. 
Thresholding  means choosing  a  threshold  value  on  the  grayscale,  below  which  all 
numerical values get the value 0 (black) and all numerical values above the threshold get 
the value 255 (white). Thus a black and white binary image is produced. This action, where 
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the  particle  to  be  analyzed  is  distinguished  from  the  background,  is  also  called 
segmentation (Carlton 2011).
If  the  binary  particle  is  incompletely  segmented,  due  to  the  inadequate  quality  of  the 
primary digital image, the binary image can be further optimized (Carlton 2011). Examples 
of this optimization include smoothing of particle edges and filling holes inside the edges. 
In order to analyze the particles they obviously also have to be separated from each other, a 
problem avoided when studying single particles (Allen 1997). Processing the images can 
however only maximize the amount of possible data to be collected, but cannot add any 
new information that did not exist in the original picture. Therefore, the most important 
factor that determines the quality of the image analysis data is the initial quality of the 
digital picture.
Microscopical imaging is usually performed only from one angle, which means that the 
orientation of the analyzed particle, at the moment of capturing an image, determines the 
two-dimensional  projection  of  the  particle  (Allen  1997,  Stainforth  and  Aulton  2007). 
Symmetrical  objects  such  as  spheres  show the  same two-dimensional  projection  in  all 
directions  and  it  is  therefore  not  important  from which  angle  the  particle  is  observed. 
However, when analyzing the particle size of asymmetrical particles i.e. fibers, it has to be 
taken into account that they have a preferential orientation at which they will tend to settle 
on a surface (Stainforth and Aulton 2007). In order to simplify the analysis of asymmetrical 
particles an equivalent diameter conversion is usually applied. The conversion is based on 
the assumption that the calculated particle volume belongs to a sphere of equal volume. 
This equivalent sphere volume can for example be calculated using the diameter of the two-
dimensional  projected  surface  area  of  the  studied  particle,  a  so  called  projected  area 
diameter. It can also be obtained based on other measurements of the analyzed particle, i.e. 
maximum and minimum perimeter diameters or circumference. 
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12 AIMS OF THE STUDY
There were five major aims in the present study:
• To study the dissolution of single particles, through image analysis data obtained by 
optical digital microscopy; 
• To investigate and verify the applicability of optical microscopy as an analytical 
technique for drug dissolution testing, by correlating the image analysis data with 
UV-spectrophotometric chemical data; 
• To design and build  a  flow-through apparatus  in  which  it  would be  possible  to 
conduct dissolution studies of freely moving single particles;
• To  compare  the  acquired  single  particle  dissolution  rate  data  with  the  Hixson-
Crowell cube root law;
• To assess the possibility of obtaining intrinsic dissolution rate data, based on single 
particle surface areas and dissolution rate data.
13 METHOD DEVELOPMENT
In order  to  study the dissolution of single  particles  of  pure drug substances by optical 
digital microscopy, two different experimental  setups, one semi-static and one dynamic, 
where developed. In order to validate the applicability of optical microscopy for dissolution 
testing, liquid samples from the same systems of single dissolving pellets were also to be 
collected and analyzed by UV-spectroscopy. When developing the methods, the limitations 
of the analytical technique and the aim of maximizing the quality of the data meant that 
certain issues had to be taken into consideration. These were the following: 
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• Due to the limited depth of focus of optical  microscopes, the particle had to be 
maintained at a fixed distance from the microscope lens;
• The magnification had to be fixed and maximized in order to enable the use of the 
same scale calibration for all images, and to achieve the greatest resolution;
• The  particle  had  to  be  sufficiently  distinguished  from the  background  and stay 
within the limits of the image area, throughout an experiment.
13.1 The semi-static setup
The limiting requirements where easily met  with the semi-static setup,  and after  trying 
different dissolution vessels a 24-well plate well was chosen (Figure 8). One well could 
hold 3 ml of dissolution medium, which was sufficient to allow adequate dissolution times 
for the studied substances, ranging from one to a few hours. The flat bottom of the well 
plates also allowed the particle to settle there for imaging, taking care of the focus issue. By 
inverting  the  microscope  (DigiMicro  2.0  Scale,  dnt  Drahtlose  Nachrichtentechnik 
Entwicklungs-  und  Vertriebs  GmbH,  Dietzenbach,  Germany)  and  imaging  the  particle 
through the transparent bottom of the 24-well plate, it was possible to use the maximum 
resolution  and  a  fixed  magnification.  The  well  plate  had  to  be  shaken  before  every 
sampling time, in order to even out the concentration in the well before collecting liquid 
samples. It was found that shaking the well plate approximately 30 seconds before sample 
collection allowed a suitable time-frame for the particle to settle at the bottom, and to move 
it  into  the  image  area  of  the  microscope.  Sample  sizes  of  1  ml  where  found  to  be 
appropriate for UV-analysis, since the UV-spectrophotometer was able to analyze samples 
of 2.5-3 ml. The minimum 2.5-fold dilution of all samples meant that smaller than 1 ml 
samples became too diluted to analyze, and larger samples disturbed the dissolution system 
too much. Larger than 1 ml samples also significantly increased the risk of sucking the 
sample pellet into the pipette. It was also found, through testing different backdrops, that a 
non-reflecting dark surface produced the highest contrast between the white drug pellets 
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and the background.
Figure 8. The semi-static single particle dissolution setup.
13.2 Einstein's teacup
Developing a dynamic setup proved to be more challenging. In previous small-scale single-
particle experimental setups, where optical microscopy has been used, the particles have 
either  been analyzed under  static conditions  (Marabi  et  al.2008)  and/or  they have been 
fixed by gluing or squeezing (Prasad et al. 2002; Raghavan et al. 2002; Börjesson et al. 
2013). The aim of the present study was however to develop a flow-through system where 
it would be possible to analyze a single, freely moving particle, which would allow certain 
advantages. Firstly, the gluing and fixing of small particles could be a laborious and time-
consuming step.  Additionally,  by gluing or  squeezing parts  of  the  surface will  become 
covered,  making it  more  difficult  to  calculate  exact  effective  surface  areas.  The  act  of 
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squeezing  should  also  theoretically  increase  the  lattice  energies  of  the  particles  by 
increasing the intraparticle tension, which in turn would have an effect on the dissolution 
rate  of  the  particles.  Furthermore,  a  freely  moving  particle  would  reflect  the  in  vivo 
conditions of particles in the GI tract more closely than a fixed particle. The free movement 
would also allow a more even agitation on, and flow across the particles, leading to more 
isotropic dissolution. Finally, a freely moving particle would not be allowed to settle in its 
preferential  orientation,  and would therefore show different area projections at  different 
time-points, enabling a three-dimensional (3D) assessment of the particle shape.
After unsuccessfully attempting a few microfluidics based flow-through systems, another 
method based on the tea leaf paradox was tried. The ”tea leaf paradox” is a common name 
for a phenomenon explained by Einstein (1926) in his paper on the meandering of rivers, 
i.e.  the tendency of streams to move in serpentine patterns, as a consequence of uneven 
erosion of opposite river banks. To explain this phenomenon he used the analogy of a flat-
bottomed teacup (Figure 9). When stirring the teacup, with tea and fragments of tealeaves 
in it,  a centrifugal force is induced in the liquid.  This centrifugal force is however not 
evenly  distributed  inside  the  teacup,  due  to  the  frictional  force  opposing  the  circular 
movement  at  the  sides  and  bottom of  the  cup.  At  the  bottom,  the  centrifugal  force  is 
especially diminished due to the interfacial friction that restrains the outward movement of 
liquid  molecules.  As  a  consequence  of  this  uneven  flow,  the  centrifugal  force  will  be 
greatest at the surface, leading to a strong outward flow. Thus, the primary circular flow 
around the teacup will be accompanied by a secondary circular flow, going outwards and 
downwards at the top and sides respectively and inwards and upwards at the bottom and 
center  respectively.  The combination  of  these two circular  flows will  produce  a  vortex 
flow-pattern in the teacup, causing the tealeaves to collect  in the middle of the bottom 
(Figure 9). This phenomenon has been applied in one previous study, where it succeeded in 
trapping  erythrocytes  from small-volume blood samples  (Yeo  et  al.  2006;  Arifin  et  al. 
2007). The stirring motion in the study was achieved by an airflow at the surface of the 
liquid, produced by the ionic wind from a small electrode.  
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Figure  9.  Eistein's  teacup  with  secondary  circular  flow  patterns  (left),  and  the  three-
dimensional vortex flow caused by the primary and secondary flows in the stirred cup 
(right) (Einstein 1926; modified from Arifin et al. 2007).
13.3 The initial apparatus and challenges
The stirring method used by Yeo et al. (2006) might not be suitable for drug dissolution 
studies, since the charge of the ionic wind might interact with drug substances, many of 
which  are  weak electrolytes.  However,  by using  the  liquid  flow to  produce  the  vortex 
pattern, a flow-through method based on the tea leaf paradox could be achieved. An initial 
apparatus was subsequently built to assess the feasibility of the chosen method in trapping 
single particles. The apparatus consisted of a glass microscope slide, two syringe needles, 
an Eppendorf tube, a rubber eraser, tubing, a syringe and a piston pump (Watson-Marlow 
503U, Smith & Nephew, Falmouth, Cornwall, England) (Figure 10). The Eppendorf tube 
was modified by cutting off the rounded bottom and making a hole through the wall at the 
lower part the tube. A larger hole was also prepared through the tube cap, in which the hub 
of a needle was fitted from the inside, and glued tight. Into this hub, from which the shaft 
had been removed, the outflow-needle was inserted from the outside. Another hole was 
drilled  through  the  flat  rubber  eraser  into  which  the  halved  tube  was  tightly  pressed, 
whereafter the eraser was glued onto the microscope slide, so that the lower rim of the tube 
pressed towards the slide. Finally, the inflow-needle was pushed through the eraser into the 
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prepared hole in the tube wall and positioned as closely as possible to the inner wall. The 
function of the eraser was thus to act as an insulator, and to hold the inflow-needle in place. 
Figure 10. The first working modified Einstein teacup prototype.
Image data was collected in the same way as in the semi-static setup, by imaging through 
the transparent bottom, which in this case was the microscope slide. When studying single 
particles in the dissolution chamber, the cap of the Eppendorf tube was closed, leaving the 
needle in the cap as the only route for liquid outflow. The inflow-needle was connected to 
the syringe in the piston pump by tubing. Because of the positioning of the inflow-needle 
opening close to the wall of the tube, the incoming flow was forced into circular motion, by 
continuous contact with the wall. Thus the apparatus was able to produce a vortex flow in 
the dissolution chamber, trapping the particle at the bottom, in a sufficiently small area to 
enable imaging. 
Several limitations and problems also occurred. The piston pump could only accommodate 
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a syringe with the maximum volume of 50 ml, which added an unfavorable step of  syringe 
changing to the process. One major issue was also the leaking of the dissolution vessel, 
caused by the high pressure buildup inside the dissolution chamber. This pressure, caused 
by the continuous inflow of fresh dissolution media, was used to force the liquid inside the 
chamber out through the outflow-needle. The seal between the outflow-needle hub and the 
tube cap was however not tight enough to withstand the force. Another initial problem was 
the forming of air bubbles on the particle surface and on the bottom of the dissolution 
chamber (Figure 11). The bubbles on the bottom prevented the rotation of the particle by 
adhering  to  it,  which  in  turn  caused  uneven  dissolution  of  the  particle,  leading  to  a 
significant change in particle shape. Additionally, the bubbles prevented an accurate and 
rapid assessment of the particle surface area. The formation of bubbles was initially thought 
to be caused by intraparticle air pockets, which would have been revealed as the particle 
dissolved. It was however later realized that the bubbles were formed on the surface of the 
particles by dissolved air in the water. The problem was consequently solved by degassing 
the water by boiling. 
Figure 11. Formation of air bubbles initially prevented an accurate assessment of the 
particle size.
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The rotating particles also caused challenges for surface area measurement, since the rapid 
movement initially resulted in blurred images (Figure 12). This issue was solved by using 
stroboscopic lighting, produced by a light emitting diode (LED) in a darkened room. The 
flashing was produced by attaching the LED to a pulse generator (TGP110 10MHz Pulse 
Generator,  Thurlby  Thander  Instruments  LTD,  Huntingdon,  Cambridgeshire, England) 
coupled  power supply (AL370S Stabilized DC Power Supply, Alpha Elettronica, Parma, 
Italy).  The fast  flashes  of light  where shorter  than the exposure time of an image,  and 
therefore produced still pictures of the rotating particle. The stroboscopic lighting however 
caused an additional problem of a dark segment in the images (Figure 12). This moving 
segment was probably caused by the rapid change in lighting during the exposure time of 
an image. It was not possible to remove this occurrence, but it was possible to control the 
width  and the  speed  at  which  the  segment  moved  across  the  screen,  by adjusting  the 
flashing frequency. There was however a limit in the rotational speeds, up to which the 
stroboscopic effect worked. At higher angular velocities of the rotating particles, the images 
again became blurred. Therefore there existed a narrow optimal region for the flow-rate, 
below which the particle did not rotate, and above which the images became blurred. It was 
also observed that the problem was magnified at higher resolutions, wherefore the highest 
resolutions  were  not  usable  at  this  initial  stage.  Additionally  the  LED had  an  optimal 
intensity at approximately 10V, below which the particle was not sufficiently illuminated, 
and above which the background became too bright. 
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Figure 12. The rotating particles initially caused blurred images (left). The problem was 
fixed using a stroboscopic LED, however, this produced another problem of a moving dark 
segment in the images (right).
13.4 The experimental apparatus
After  verifying  the  functionality  of  the  modified  Einstein  teacup  named  flow-through 
apparatus,  and  identifying  the  critical  issues  and  parameters,  further  optimization  was 
carried out. The initial apparatus was miniaturized to the 96-well plate size, which is the 
norm for drug discovery physicochemical screening methods (Kerns 2001). To produce an 
inlet to a well for the vortex producing needle, a narrow groove, that barely punctuated the 
bottom corner of the well to be used, was cut along the bottom of the 96-well plate. Into 
this groove the inflow-needle was fitted and adjusted, so that the final positioning of the 
opening of needle was as close as possible to the bottom corner of the well (Figure 13). The 
needle stayed well fixed inside the tight groove, but was additionally fixed by gluing. It was 
found that the most effective flow pattern was produced when the incoming liquid was 
allowed to initially flow tangentially to the wall. On the contrary, if the inflow-needle was 
pushed inward, so that the flow was more towards the wall, the flow pattern got disturbed. 
The outflow-needle was prepared by bending the last centimeter of the shaft in a 90° angle. 
This needle  was then fixed to  the well  plate  by a strong holder clip,  in  a manner  that 
positioned the bent end of the needle vertically in the center of the chamber (Figure 13). 
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This was the positioning found to produce the most centered and even flow pattern. 
Figure 13. The 96-well plate modified Einstein teacup flow-through system, pictured from 
above (left) and below (right).
The piston pump was exchanged for a peristaltic pump for the new setup, in order to avoid 
the problematic changing of syringes during the experiments (Figure 14). Additionally, the 
connecting of the tubing was changed so that both inflow and outflow were regulated by 
the same peristaltic pump, with the same flow rate (Figure 15). As a consequence of this, 
the medium was removed from the dissolution chamber at the same rate as fresh medium 
was pumped in.  This eliminated the problem of pressure buildup, avoiding the leakage 
issue and allowing an open system without the need for a closing cap. It was found that a 
25 rpm setting on the pump produced a flow rate of 5 ± 0.05 ml/min (n=3), which was 
suitable for rotating the particle, image acquisition and liquid sample collection. Because all 
the collected medium was from the dissolution chamber, this meant that sample volumes of 
5, 10 and 25 milliliters corresponded to dissolution times of 1, 2 and 5 minutes. This in turn 
made sample collection easy and reproducible, since timekeeping was not needed and the 
occasional air that was sucked into the outflow tube did not affect the results. It was also 
found  that  stroboscopic  lighting  from  below  produced  the  best  images,  and  that  the 
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maximum resolution could be used by optimizing the microscope settings. Additionally it 
was  observed  that  approximately  every  fifth  picture  was  of  desired  quality  and  the 
maximum image capturing rate of 6 images/min was therefore used for the microscope. To 
make the setups more robust and repeatable both the semi-static and dynamic apparatus 
where fixed onto a wall. In the semi-static setup the microscope was bolted to the wall, and 
a shelf was mounted for the 24-well plate, which allowed the replacing of the well plate at 
the  same  distance,  after  every  shaking  step  (Figure8).  In  the  dynamic  setup  both  the 
microscope and the 96-well plate where fixed to the wall. Hence, the magnification and 
positioning where maintained throughout an experiment and also between experiments.
Figure 14. The modified Einstein teacup flow-through setup.
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Figure 15. Close-up of the modified Einstein teacup setup.
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14 MATERIALS AND METHODS 
14.1 Materials
Pure substance pellets of the initial weight range 0.20-0.85 mg where used in the single 
particle  dissolution  studies.  The  pellets  where  produced  from  micronized  powders  of 
anhydrous  theophylline  (theophylline  anhydrous,  BASF,  Ludwigshafen,  Germany)  and 
acetylsalicylic acid (ASA) (acetylsalicylic acid, Orion Pharma, Espoo, Finland) (Table 4), 
using  a  miniaturized  spheronization  method  recently  developed  at  the  Division  of 
Pharmaceutical  Technology,  Faculty  of  Pharmacy,  University  of  Helsinki  (D'Hollander 
2013). Pellets of other substances of higher and lower solubilities where also attempted, but 
the higher solubility pellets where too friable and the lower solubility pellets dissolved too 
slowly  in  water  to  produce  feasible  experiment  times.  However,  despite  both  studied 
substances having similar qualitative solubilities, the differences in dissolution behavior 
between these two substances produces an interesting case to be studied.
Table 4. Physicochemical properties of theophylline and acetylsalicylic acid
Physicochemical property Theophylline Acetylsalicylic acid
Solubility according to 
Ph.Eur 7.8 (2013b)
Slightly soluble 
(1-10 mg/ml)
Slightly soluble 
(1-10 mg/ml)
Water solubility* 
(mg/ml; 25°C) 7.36 4.60
Melting point* (°C) 273 135
pKa* 8.81 3.49
logP* -0.02 1.19
*ChemIDPlus Advanced 2013
58
14.2 Methods
All experiments where done in triplicate, i.e. three semi-static and dynamic experiments for 
both theophylline and ASA pellets, respectively, in order to get statistical reference groups, 
with which the individual single particle dissolution data could be compared. This would 
allow the assessment of the repeatability and accuracy of the methods. The experiments are 
henceforth referred to as AS1,AS2,AS3 and TS1,TS2,TS3 for the three semi-static ASA and 
theophylline  experiments,  respectively,  and  AD1,AD2,AD3  and  TD1,TD2,TD3  for  the 
three dynamic ASA and theophylline experiments, respectively. Image data was acquired 
using a digital optical microscope (DigiMicro 2.0 Scale, dnt Drahtlose Nachrichtentechnik 
Entwicklungs-  und  Vertriebs  GmbH,  Dietzenbach,  Germany)  under  optimal  setup 
conditions,  determined  during  the  method  development,  and  listed  in  chapter  11.  The 
microscope was connected to a computer via the PC USB port and controlled with the 
accompanying  software  (MicroCapture  V2.0,  dnt  Drahtlose  Nachrichtentechnik 
Entwicklungs- und Vertriebs GmbH, Dietzenbach, Germany). The software enabled either 
manual or timer-controlled image capturing, which were used in the semi-static and the 
dynamic methods respectively. All pellets where weighed using an analytical balance with 
an  accuracy  of  0.01  mg  (DeltaRange  AX105,  Mettler-Toledo  GmbH,  Greifensee, 
Switzerland). The accuracy of the scale was affirmed by weighing ten pellets three times 
each and one pellet ten times. It was found that the standard deviation for both weighings 
was 0.01 mg. 
As discussed in chapter 2, there are a multitude of factors that affect the dissolution rates of 
solids in liquids. However, all these factors, apart from the density of the pellets, would 
have equally affected the results from physical and chemical analysis. Therefore, because 
the main aim of the present study was to correlate image analysis and absorbance data, 
from the same systems of a dissolving pellet, the factors are not of relevance for the results. 
The density issue will be discussed in upcoming chapters. Liquid sample collection and 
solvent replacement in the semi-static experiments, as well as all UV-sample pipetting, was 
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performed using the same Finnpipette (Finnpipette® 4027, Thermo Fisher Scientific Inc., 
Waltham, Massachusetts, USA). Because of the small sample sizes, the relative impact of 
any deviations in volume would have been pronounced. Therefore, only one pipette was 
used, in order to avoid calibration related sources of error. The necessity of filtrating was 
investigated by analyzing samples from three different time-points of a theophylline and 
ASA single particle dissolution assay, with and without filtrating (Table 5). It was found 
that the difference in absorbance was randomly higher for either filtrated or non-filtrated 
samples,  and  that  the  calculated  concentration  difference  was  on  average  below  1%. 
Filtration was therefore determined as not being necessary in this case.  The dissolution 
medium in all experiments was degassed distilled water. The degassing was carried out by 
boiling  the  water  for  5  minutes.  Immediately  after  boiling  the  liquid  was  filled  into 
containers and tightly sealed with a screw lid. The hot containers where then left overnight 
to allow the temperature to stabilize. All tests where performed at ambient temperature, and 
the temperature of the medium was recorded at the beginning, middle and end of every 
experiment. Finally, the liquid samples where analyzed with a UV-spectrophotometer (UV-
1600PC Spectrophotometer,  VWR International,  Leuven,  Belgium)  and  image  analysis 
performed, as discussed in chapter 14.2.4. 
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Table  5.  UV-spectrophotometric  data  of  filtered  and  non-filtered  samples,  and  the 
difference  in  absorbance  units  (AU)  and  in  percental  concentration.  The  difference  in 
absorbance units was randomly larger or smaller, and the difference in concentration on 
average below 1 %. Filtration was therefore determined not to be necessary in this case
Theophylline
Non-filtrated 
(AU)
Filtrated 
(AU) Difference in absorbance units
Difference in 
concentration (%)
1 0.8357 0.8360 -0.0003 0.04
2 0.7774 0.7762 0.0012 0.16
3 0.8864 0.8876 -0.0012 0.14
ASA
1 0.2627 0.2642 -0.0015 0.67
2 0.1692 0.1685 0.0007 0.54
3 0.1167 0.1180 -0.0013 1.68
14.2.1 The semi-static method
Before beginning a semi-static experiment, an image was taken of the weighed pellet in a 
cleaned and dried well of the 24-well plate. The experiment was then initiated by adding 3 
ml of dissolution medium to the well. The following sampling time-points were at 2, 5 and 
10 minutes, and after this every 5 or 10 minutes depending on the initial weight of the 
particle. When approaching the end of the experiments in which 10 minute intervals were 
used, sample collecting was again shifted to every 5 minutes, increasing the frequency of 
data points. This was necessary since the data obtained from the dissolution process became 
increasingly inaccurate  towards  the final  stages.  Between two sampling-points  the  well 
plate was kept untouched upon the custom mounted shelf, with the lid on. Thirty seconds 
before  each  sample  collection,  the  contents  of  the  dissolution  vessel  were  agitated  by 
turning the well plate upside down three times with a frequency of one turn per second, 
thus producing a more uniform concentration for pipetting. 
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After each shaking step, the pellet was allowed to settle at the bottom of the well. The well 
plate was then placed on the shelf, so that the whole particle was visible in the image, and 
an  image  was  subsequently  captured  at  approximately  the  predetermined  time-point. 
Following  this  a  1  ml  medium  sample  was  pipetted  and  put  into  a  small  test  tube. 
Immediately after emptying the sample into the test tube, the tip of the Finnpipette was 
changed and an equal volume of dissolution medium added into the well to replace the 
removed  sample.  The  time  was  recorded  for  both  image  capturing  and  liquid  sample 
collecting. This process was continued until the particle size had decreased, so that it no 
longer could be detected with the microscope. Immediately following an experiment the 
liquid  samples  where analyzed with the UV-spectrophotometer,  which  had  an accuracy 
optimum in the range of 0.5 – 1 absorbance units (AU). Since the liquid samples where 
dilute, the additional mandatory dilution was always started from the smallest volume, i.e. 
1.5 milliliters of added water. The dilution of subsequent samples with 1.5 milliliters was 
continued until the absorbance value approached the value of 1, after which the diluent 
volume was increased upwards in a stepwise manner. When again approaching the value of 
0.5 AU, towards the end-point samples, diluent volumes where decreased downwards. Thus 
the absorbance value was always kept inside the optimal limits, except for the cases where 
the minimum dilution of 1.5 ml produced absorbance values below 0.5.
14.2.2 The modified Einstein teacup method
The 96-well plate modified Einstein teacup dissolution chamber was washed between every 
experiment by pumping 200 ml of degassed distilled water through the system. In this way 
any residues from previous experiments were removed. Before initiating a single pellet 
dissolution  test,  all  liquid  had  to  be  removed  from the  tubing,  in  order  to  allow  the 
measuring of accurate volumes from the dissolution chamber. The emptying of the tubing 
was achieved by pumping air at maximum speed through the system, with an inversed flow 
direction. The inversed flow at high speed also created a very strong spray of water from 
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the outflow needle towards the bottom of the cup, as well as a strong suction out from the 
well through the inflow needle at the bottom. This caused an effective final washing of the 
dissolution chamber. When all  liquid had been removed from the system, the flow was 
inversed back  to  normal,  and dissolution  medium pumped into the inflow tube  until  it 
reached the inflow-needle hub. 
The experiments where initiated by turning on the stroboscopic lighting and the timer on 
the image capturing software, using the maximum timer rate of 6 images/minute. During 
the experiments the room was darkened, leaving the flashing LED as the only source of 
illumination. After these preparations a drug pellet was put into the dissolution chamber, 
whilst  simultaneously  turning  on  the  peristaltic  pump.  The  liquid  inflow  began 
immediately, since the medium had been prepumped into the inflow tube. By starting the 
image acquisition before turning on the liquid flow, it was possible to determine the exact 
starting-point  of  an  experiment  from  the  first  image  in  which  liquid  was  observed. 
Dissolution medium samples from the outflow tube were collected in 5 and 10 ml scaled 
test tubes and 25 milliliter volumetric flasks. The collection time-points were 1 (5ml), 3 (10 
ml)  and 5 (10 ml)  minutes  and after  this  every 5 (25 ml)  minutes until  the end of an 
experiment. Because the samples where already very dilute, and the amounts sufficient to 
fill the UV-spectrophotometer cuvette, no additional dilution was needed.
14.2.3 Calibration curves and UV-spectrophotometry
Calibration  curves  for  theophylline  and ASA were  produced  by first  scanning  the  UV 
spectra for a standard sample, from 200-500 nm, with 0.1 nm intervals. It was found that 
theophylline  had  an  absorption  maximum  at  203.2  nm  and  ASA at  200.0  nm.  These 
wavelengths where subsequently used in quantitations. Samples ranging over a ten-fold 
difference in concentration, 1 μg/ml – 13 μg/ml (n=10) for theophylline and 3 μg/ml – 40 
μg/ml (n=6) for ASA, where analyzed and the calibration curves plotted. A first degree 
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polynomial fit was then made to the absorbance (y) against concentration (x) plotted data, 
producing the equations y = 146.2x + 0.03 (R2=0.999) for theophylline, and y = 41.5x + 
0.12 (R2=0.997) for ASA. These equations where used to convert absorbance values of the 
samples into concentrations. Between every sample the cuvette was washed, with the same 
medium as used in the assay, and wiped on the outside with a clean cloth, whereafter the 
cleanliness  was  visually  inspected.  The  same  dissolution  medium  was  also  used  for 
possible dilutions and for blanking before each set.
14.2.4 Image processing and analysis
Image analysis was similar for both the semi-static and dynamic methods and is therefore 
discussed commonly in this section. Before the first experiments of both methods an image 
was taken of a micrometer graticule for subsequent calibration of the scaling. The graticule 
was imaged again before every semi-static experiment in order to ensure the constancy of 
the  calibration.  Because  the  dynamic  apparatus  was  fixed  to  the  wall  throughout  the 
experimental phase, any tampering with the equipment would have caused disturbances in 
the  experimental  setup.  This  hindered  the  verification  of  the  calibration  scale  between 
experiments.  Consequently  the  fixed  magnification  was  controlled  before  every 
experiment, and the calibration assumed to be constant in all subsequent analyses. Because 
of the large amount and generally suboptimal quality of the dynamic method images, all 
acquired  images  could  not  be used for  analysis.  Since  the  dynamic  experiments  lasted 
between 30 and 85 minutes, it was decided that one image, of representative quality, every 
one or two minutes would be appropriate, both in regard of the workload of the processing 
and the sufficiency of data points. In order to get a better representation of the average 
projected surface area, an attempt was also made, whenever possible, to select images close 
in  time to  each other  in  which  significant  variations  of  the  projected surface  area was 
observed.
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After the images had been selected, they were processed and subsequently analyzed using 
the  public  domain  ImageJ  software  (ImageJ  1.46r,  U.S.  National  Institutes  of  Health, 
Bethesda, Maryland, USA). The images from the semi-static setup were generally of good 
quality and therefore easily segmented, without the need for any substantial removal of 
background noise (Figure 16). After binary conversion the images were analyzed using the 
built in particle size analysis tool of the software. Besides calculating the equivalent sphere 
surface area, the analysis  data also contained several  other parameters such as different 
diameters, the aspect ratio, circularity and roundness of the particle. 
Figure 16. A typical single particle image from the semi-static method.
Images from the dynamic experiments however required more elaborate processing (Figure 
17). The first step was typically to enhance the contrast of the image in order to better 
distinguish the edges of the pellet. This was done before conversion to monochrome, since 
the  particle  edges  where  better  distinguished  in  color  images.  After  the  contrast 
enhancement, background noise had to be removed manually in cases where parts of the 
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background where of the same brightness as darker parts of the pellet. This was done to 
allow a successful segmentation of the image by thresholding. If areas of the background in 
contact with brighter parts of the pellet would have had the same brightness as the darker 
areas of the pellet, both the background and the darker areas of the pellet would have been 
removed during segmentation.  After thresholding,  the images where made monochrome 
and converted into black and white. The binary images where then further processed with 
the  'close'  command,  which  smoothed  the  edges  of  the  particles  in  areas  where  the 
segmentation had been incomplete. Also the 'fill holes' technique was applied to fill white 
areas inside of the black particles edges. Finally, the images where analyzed as in the semi-
static case. 
Figure 17. Typical single particle image from the Einstein teacup method.
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14.2.5 Correlating physical and chemical data
To  compare  image  analysis  and  absorbance  data,  it  was  found  that  the  weight  of  the 
particles had to be normalized. This was due to the fact that the measured initial weights of 
the particles where not always equal to the weights predicted from UV-spectrophotometric 
data, which caused deviations of the dissolution profiles in these assays. Since, due to the 
limitations of the analytical equipment, it was not possible to observe the end of the single 
particle dissolution profiles, by either microscopy or UV-spectrophotometry, the endpoint 
and total cumulative amount dissolved had to be calculated. To normalize the weight, a 
second degree polynomial fit was performed to the decreasing curve of surface area per 
time. The extrapolated endpoint from this second degree fitting was used as the end point of 
an  experiment.  This  value  was  then  inserted  in  the  third  degree  polynomial  fit  of  the 
absorbance  data  dissolution  curve,  and  thus  the  total  amount  of  mass  dissolved  was 
acquired.  This  value  was  used  to  normalize  both  the  image  analysis  and  absorbance 
dissolution curves,  as percent released per time. The initial pellet  surface area was also 
extrapolated from the second degree fitting of the surface area per time plot.  This was 
necessary since the initial  surface area projection of a  dry pellet  before the start  of  an 
experiment was found to be constantly smaller than the first projections after the start of an 
experiment. This occurrence was also observed by Marabi et al. (2008) and Börjesson et al. 
(2013),  who explained the occurrence with a swelling of the particle after  coming into 
contact with the dissolution medium. The apparent increase in size could, however, also be 
a consequence of the different optical properties of air and the denser dissolution medium.
When comparing two dissolution profiles the FDA advocates the use of a similarity factor, 
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( ) 







−



+=
−
=
∑ 100*11log*50
5.0
1
2
2
t
tt
n TR
n
f                             (27)
67
where n is the number of samples, Rt is the percental dissolved amount of the reference 
curve at time, t and Tt is the percental dissolved amount of the test curve, at the same time-
point (FDA 2000, Costa and Sousa Lobo 2001). The equation calculates the logarithmically 
converted  sum-squared  error  of  the  two curves,  over  all  data  points,  and  gets  a  value 
between 0 and 100 depending on the similarity. Two curves are regarded as similar for f2 
values over 50, which indicates an average of less than 10% difference in the dissolution 
curves (FDA 2000).  Another  factor  that  correlates  the dissolution curves  over all  time-
points is the difference factor, f1, 
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which calculates the percental difference between two curves over all data points, with a 
value below 15 considered as proving equivalency. Since the images and liquid samples 
where not collected at the same time-points, third degree polynomial fits where used to 
calculate the similarity and difference factors.
The similarity and difference factors can be calculated from data sets of more than four data 
points (FDA 2000). The values are however also susceptible to the number of sampling 
points, with a higher n value leading to better correlation. Therefore it is suggested that no 
more than one sample, past the point where 85% of the initial mass has dissolved should be 
used. In the present study it was however important to compare the dissolution curves over 
the whole range from 0 – 100%. Since the values where calculated from the third degree 
fittings, it was decided that ten data points would be enough to allow accurate assessment 
of the f2 and f1 values, and few enough not to cause an improvement of the data. Thus the 
final time-point of an experiment was chosen as the tenth data point, and the other nine data 
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points where calculated so that the difference between each data point was equal. The data 
from chemical analysis was used as reference in all calculations. To visualize the collective 
data of the three pellets from an experiment setup, plots normalized both with regard to 
mass dissolved and time, were also needed. The normalized time values were calculated as 
percental differences from the final time-point.
14.2.6 Evaluating the relationship of the obtained single particle data with the Hixson-
Crowell cube root model and the calculation of intrinsic dissolution rates
The  relationship  between  the  data  of  the  single  dissolving  particles,  and  dissolution 
following the Hixson-Crowell cube root law (Equation 12), was investigated by plotting  w0  
1/3 – w  1/3 against time. Of the three single particle dissolution models (modifications of 
Equation 14) the Hixson-Crowell cube root law is the model best suited to describe the 
dissolution rate in the size range of the pellets used in the present study. This is because it 
has been shown that the Hixson-Crowell cube root law is the most accurate of the three 
equations, in modeling the dissolution of spherical particles larger than their diffusion layer 
thickness (Wang and Flanagan 1999). The pellets used in the present study are significantly 
larger than their diffusion layer thicknesses, throughout the major part of the experiments. 
The  IDRs  where  calculated  by  plotting  the  cumulative  amount  dissolved,  against  the 
average surface area up to that time-point. The surface area was derived from the second 
degree curve fit, and the average value was received by dividing the time-point with two 
and inserting this value into the fitting. Only data from image analysis was used in these 
calculations, since it was the primary objective of this study to demonstrate the usability of 
this particular data.
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15 RESULTS AND DISCUSSION
15.1 Validation of image analysis data
Validation of optical microscopy as analytical technique, by comparison to conventional 
analytical techniques, has not been performed in the previous single particle dissolution 
studies (e.g. Prasad et al. 2002; Raghavan et al. 2002; Marabi et al. 2008; Börjesson et al. 
2013). There can therefore have been no certainty of the accuracy of the obtained image 
analysis data. In the present study the validation was, however, performed. There were two 
assumptions involved in the analysis of the dissolution data of the single particles. Firstly, 
the density was assumed to be evenly distributed throughout the particles. This assumption 
is discussed in relation to individual experiment data in the following chapters. Secondly, 
isotropic dissolution, where the pellets keep their spherical shape throughout the dissolution 
process, was assumed. The sphericity can be assessed by analyzing the change in aspect 
ratios of the pellets (Table 6). It can be seen from this data that the average aspect ratios of 
the particles ranged between 1.09 and 1.22, with small standard deviations. This indicates 
the retaining of a spheroidal shape throughout the experiments, for all particles, which is in 
line with results from other single particle assays where spherical particles have been used 
(Parrott et al. 1955, Marabi et al. 2008). 
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Table 6. Initial weight, aspect ratios and the change (+/0/-) in the aspect ratios during single 
particle experiments. A general tendency for increased and decreased aspect ratios for the 
static (T/ASX) and dynamic (T/ADX) experiments, respectively, can be observed
Experiment Initial weight (mg) Initial aspect ratio Average aspect ratio with 
standard deviation
Change
TS1 0.45 1.09 1.11 ± 0.06 +
TS2 0.85 1.17 1.22 ± 0.07 +
TS3 0.27 1.08 1.19 ± 0.06 +
AS1 0.20 1.11 1.19 ± 0.07 -
AS2 0.41 1.09 1.09 ± 0.05 0
AS3 0.66 1.10 1.10 ± 0.05 0
TD1 0.24 1.18 1.13 ± 0.06 -
TD2 0.62 1.14 1.11 ± 0.06 -
TD3 0.26 1.14 1.13 ± 0.10 -
AD1 0.71 1.12 1.11 ± 0.06 -
AD2 0.75 1.11 1.18 ± 0.09 +
AD3 0.29 1.20 1.22 ± 0.11 +
A general trend of slightly increasing aspect ratio, from the initial value, can be observed 
for the semi-static experiments. Especially the two smallest particles, TS3 and AS1, showed 
an  increase  from the  initial  aspect  ratio.  This  could  be  due  to  the  buildup  of  uneven 
concentration gradients around the stagnant particles. As was shown by Østergaard et al. 
(2011), the concentration around a dissolving single particle, in a stagnant liquid, is always 
highest towards the bottom. This would cause different concentration gradients (CS – Ct) 
around  the  single  pellets  which  would  lead,  according  to  the  Noyes-Whitney  equation 
(Equation  4),  to  varying  dissolution  rates  from  different  parts  of  the  pellet  surface. 
Additionally Østergaard (2011) and coworkers showed that density gradients in the liquid 
led to  uneven convection around the particles,  which would further  have enhanced the 
anisotropic dissolution. The general trend in the dynamic experiments is on the other hand a 
constant or decreased aspect ratio, from the initial values, and no dependency on initial 
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particle weight can be observed. It thus seems that the modified Einstein teacup method 
with a constant flow and sink conditions around the rotating particle, was able to produce a 
more isotropic  dissolution with a  tendency towards higher  sphericity for  the dissolving 
pellets. 
15.1.1 The semi-static method
The semi-static system was exposed to varying conditions throughout an experiment. In the 
beginning sink conditions would have prevailed and, for a short time, the dissolution rate 
would have been intrinsic dissolution rate driven. However, the lack of agitation between 
sampling-points, very quickly would have established a growing diffusion layer around the 
dissolving particle, as shown by Østergaard et al. (2011). The dissolution rate would then 
have been diffusion limited, following Fick's I law of diffusion (Equation 1). When the 
contents  were  mixed,  the  diffusion  layer  would  have  decreased  and  consequently  the 
driving force (CS – Ct) of the Noyes-Whitney equation (Equation 4) would have increased 
(Hixson and Crowell 1931). The concentration gradient (CS – Ct) would have been further 
increased by removing of sample, and subsequent replacement with fresh solvent, leading 
to  even higher  dissolution  rates.  After  sampling,  this  cycle  would  have  been  repeated, 
starting with a buildup of a diffusion layer in the stagnant liquid. 
The purpose of the semi-static method was,  however,  only to establish a correlation of 
dissolution rate data from image analysis and UV-spectrophotometry. To this end the semi-
static method was very suitable. Due to the static conditions during the capturing of an 
image,  the  image  quality  was  good  and  the  images  easily  processed  (Figure  16).  The 
stagnant medium also allowed the sometimes uneven particles to settle in their preferential 
position,  leading  to  constant  overestimation  of  the  particle  volume.  Since  the 
overestimation was constant, it did not notably affect the results. This is because the mass 
dissolved from an overestimated volume was calculated based on the density of the initial 
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overestimated volume. The data of the individual particles used in the semi-static method 
are represented in  Table 7. It can be seen that the correlation data of the ASA pellets are 
very good, with an average (± standard deviation) R2 value of 0.988 ± 0.013 and an average 
similarity factor (f2) of 76 ± 27. Henceforth, average values are reported as mean ± standard 
deviation. The similarity (f2) and difference (f1) factors are even better, around 90 and 2 
respectively, for two out of three ASA single particle experiments, demonstrating almost 
identical curves, as can be seen in Figure 18. 
Table  7.  Correlation of  physical  and chemical  analysis  data  from the semi-static  single 
pellet experiments of acetylsalicylic acid (ASX) ant theophylline (TSX), as well as physical 
factors affecting the results. Average values are presented with standard deviation in the 
relevant cases. The similarity factors (f2) and difference (f1) factors indicate the very high 
similarity of physical and chemical analysis data 
Expeiment R2 f2 f1 Weighed mass 
(mg)
Predicted mass 
(mg)
Density 
(mg/mm2)
AS1 0.974 45 15 0.20 0.15 0.67
AS2 0.993 89 2 0.41 0.42 0.64
AS3 0.998 94 1 0.66 0.67 0.62
Average 0.988 ± 
0.013
76 ± 27 6 ± 8 0.42 0.41 0.64 ± 0.03
TS1 0.980 81 3 0.45 0.40 0.66
TS2 1.000 96 1 0.85 0.83 0.67
TS3 0.996 96 1 0.27 0.25 0.67
Average 0.992 ± 
0.011
91 ± 9 2 ± 1 0.54 0.49 0.67 ± 0.01
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Figure 18. Dissolution curves of physical (Image) and chemical (UV) analysis data from a 
semi-static  acetylsalicylic  acid  single  pellet  experiment  (AS3) (left)  and the correlation 
curve of the data sets (R2=0.998) (right).
The higher deviation in the ASA1 experiment was a result of a deviating chemical analysis 
curve for this sample. This can be clearly seen in Figure 19 where the one deviating UV 
dissolution  curve  shows a  continuously  higher  dissolution  rate,  when  compared  to  the 
collective data. The same is also visualized in Figure 20, where the standard deviation of 
the weight and time normalized UV dissolution curve is significantly higher that that of the 
image analysis dissolution curve. There are two possible causes for the deviating AS1 data. 
First, it can be seen that the pellet had a larger than average difference in weighed and 
predicted  mass,  which  could  cause  a  erroneous  normalization  of  the  percentual  mass 
dissolved  for  the  absorbance  data  (Table 7).  The  other  cause  of  error  might  be  the 
inaccuracy of the UV-spectrophotometer. Since the AS1 pellet mass was the smallest of the 
three, it consequently produced the most diluted samples, of which 10/18 had absorbance 
values below the optimum of 0.5 AU. The four last data points of experiment AS2, that 
show a clear deviation from the previous data points, were an anomaly that could not be 
explained.  However,  the  data  points  are  equally  observed  in  both  image  analysis  and 
absorbance  data,  which  means  that  it  was  not  caused  by  an  error  in  either  analytical 
technique. The significant deviation from the prior rate profile could have been caused by 
the mixing. If there was a significantly porous and friable area in the pellet, the agitation 
could have caused it to disintegrate and thus rapidly dissolve. As discussed by Yu et al. 
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(2004), the disintegration of the studied solid would cause an increase in the dissolution 
rate.
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Figure 19. Collective acetylsalicylic acid single pellet dissolution curves of all three semi-
static  experiments,  from UV-spectrophotometric  (UV) and image analysis  (Image) data. 
The constantly deviating absorbance curve of sample AS1 is observed.
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Figure  20.  Average  (n=3)  acetylsalicylic  acid  dissolution  curves  from  UV-
spectrophotometric (UV) and image analysis  (Image) data from the semi-static method, 
with standard deviation. A clearly higher standard deviation, caused by one deviating curve, 
of the absorbance data can be observed.
Physical and chemical data from the theophylline single particle experiments did not seem 
to correlate very well at first. However the R2 value was very high for all experiments and it 
was found that the dissolution curves varied by a constant value over all time-points (Table 
7). As shown by D'Hollander (2013) in her masters thesis, developing the miniaturized 
pelletization  method,  the  anhydrous  theophylline  pellets  recrystallized  as  theophylline 
monohydrate after  the wetting process. Since the calibration curve for theophylline was 
produced from theophylline anhydrate powder, a correction factor of 1.0999, which is the 
ratio of the MW's of theophylline anhydrate/theophylline monohydrate, was used to correct 
the UV-absorbance data. This resulted in significantly higher correlations. The theophylline 
pellets  all  produced similar  results,  with average f2 and f1 values of 91 ± 9 and 2 ± 1 
respectively (Table 7). This shows a very high similarity between the physical and chemical 
data, as depicted in Figure 21, with an average 2 ± 1% difference over all data points. 
76
0
10
20
30
40
50
60
70
80
90
100
0 20 40 60 80 100 120 140 160 180
Time (min)
A
m
ou
nt
 d
is
ol
ve
d 
(%
)
UV Image
R2 = 1.000
0
10
20
30
40
50
60
70
80
90
100
0 10 20 30 40 50 60 70 80 90 100
%- dissolved (Image data)
%
- d
is
so
lv
ed
 (U
V 
da
ta
)
Figure 21. Dissolution curves of physical (Image) and chemical (UV) analysis data from a 
semi-static theophylline single pellet experiment (TS2) (left) and the correlation curve of 
the data sets (R2=1.000)(right).
There was again one experiment that produced slightly lower correlation. This TS1 sample 
showed the greatest variation in measured and predicted particle weight, as was the case 
with the AS1 pellet. The data from experiment TS1 could have been predicted to be the 
most accurate of the three theophylline pellets, since it had the lowest aspect ratio (1.09 ± 
0.07)  and  the  highest  roundness  (0.92  ±  0.05)  throughout  the  experiment.  A possible 
difference  in  density  could  therefore  be  the  cause  of  this  result.  Parrot  and  coworkers 
(1955) concluded that the dissolution rate was independent of the density of the particles. 
Similar results where shown by Yu et al. (2004) who found that the dissolution rate, when 
using the rotating disc method, was not notably affected by the compression force applied 
when  producing  the  studied  sample.  However,  both  of  these  studies  used  compressed 
samples, and it can therefore be assumed that the density of their samples would have been 
significantly  higher,  and  more  evenly  distributed,  than  what  is  the  case  with  non-
compressed pellets. 
As shown by Börjesson et al. (2013) the intraparticle porosity of spherical particles can be 
significant.  They assumed  that  this  unevenly distributed  density  was  the  cause  for  the 
varying dissolution rates,  for single dissolving particles. Since, in the present study,  the 
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density of a pellet was assumed to be constant throughout the whole pellet, particle size 
analysis  of  the dissolution from a lower density area would cause an erroneously high 
interpretation of the mass dissolved. However, the weight normalized TS1 dissolution curve 
from image analysis data showed a slightly lower dissolution rate than absorbance data, and 
it is therefore assumed that the weight of the TS1 pellet was the primary cause of error. The 
strong correlation of the overall, weight and time normalized data, can be seen in Figure 22 
and the slightly higher standard deviation of average (n=3) dissolution rate data from image 
analysis can be seen in Figure 23. The deviation in image analysis data can be explained by 
the  fact  that  the  particles  where  not  perfectly  spherical,  and  a  misinterpretation  of  the 
particle size was therefore possible. As discussed, intraparticle density variations might be 
another source of error as well as the image processing. Despite of these possible sources of 
inaccuracy, the overall data shows surprisingly little variation. 
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Figure 22. Collective theophylline single pellet dissolution curves of all three semi-static 
experiments, from UV-spectrophotometric (UV) and image analysis (Image) data.  A very 
high similarity can be seen.
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Figure  23.  Average  (n=3)  theophylline  dissolution  curves  from  UV-spectrophotometric 
(UV)  and  image  analysis  (Image)  data  from  the  semi-static  method,  with  standard 
deviation. A slightly higher standard deviation of the image analysis data can be observed.
From the semi-static data it can concluded that a very high correlation of physical data from 
image analysis  and chemical data from UV-spectrophotometry is  achieved.  Most of the 
dissolution curves are practically identical and where discrepancies are observed, these can, 
mostly, be explained by lacking accuracy of the analytical apparatus used and not so much 
by the image analysis method. It can also be seen that where accurate measurements of 
particle mass and chemical data are achieved, the single experiments actually give a better 
correlation than the average data.
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15.1.2 The modified Einstein teacup method
The novel 96-well plate modified Einstein teacup succeeded in trapping the single freely 
moving particles in a sufficiently small area to allow their microscopic imaging. The flow-
through setup is assumed to have been sufficient to produce constant sink conditions, since 
5 ml of fresh liquid was pumped through the 300 μl well every minute (Mosharraf and 
Nyström  1995).  This  would  have  made  the  dissolution  rate  solubility  and  intrinsic 
dissolution rate driven throughout the experiments, in accordance with the Noyes-Whitney 
equation  (Equation  4).  The  sink  conditions  where  also  a  prerequisite  for  the  Hixson-
Crowell cube root law correlation and the IDR calculations, which are discussed in the 
following  chapters  (Hixson  and  Crowell  1931;  USP 2001).  The  correlation  results  of 
physical and chemical data from the dynamic method are not as high as for the semi-static 
method. This was expected since the dynamic method contained several more variables 
and, therefore, possible sources of error. It can be seen in Figure 24 that limited image 
analysis data was received during the first minutes of the experiments. This was due to the 
fact that the initially large rotating pellets tended not to be fully visible in the imaging area, 
which prevented the calculation of the projected surface area. The problem disappeared 
with  decreasing  particle  size,  since  the  smaller  pellets  remained  for  longer  periods 
completely inside the imaging area. Also other challenges such as the not as good image 
quality, and the consequently increased processing, caused more variability in the image 
analysis data from the dynamic experiments. 
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Figure 24. Dissolution curves of physical (Image) and chemical (UV) analysis data from a 
modified  Einstein  teacup  theophylline  single  pellet  experiment  (TD1)  (left)  and  the 
correlation curve of the data sets (R2=0.995) (right).
The rotating pellets showed quite different area projections in successive images, which led 
to  a  sometimes  strong  oscillation  in  the  calculated  amount  dissolved.  The  variability, 
however, evened out over time, and gave a good representation of the average 3D particle 
size. Because only one image every one or two minutes was used, the data could possibly 
have been more accurate if more data points could have been analyzed. The acquisition of 
more data points is, however, easily achieved using more sophisticated equipment, with 
which it would be possible to analyze image data more frequently and with better accuracy. 
While the dissolution curves might seem to be similar to those of the semi-static method, 
this  is  an  illusion  caused  by the  decreasing  effective  surface  area  of  the  single  pellets 
(Equation 17). If the surface would have been kept constant throughout the experiments, 
the dissolution curves would have followed zero-order kinetics and produced straight lines 
(Yu et al. 2004). 
Despite the many possible sources of error, the correlation is very high as seen in Table 8. 
For the theophylline pellets, the average f2 value of 69 ± 12 is clearly above the value of 50, 
which according to the FDA is required to indicate similarity of two curves (FDA 2000). 
The average difference factor of 6 ± 4 also clearly demonstrates the similarity of the curves. 
From the weight and time normalized data in Figures 25 and 26 it can be notated that the 
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absorbance  data  produces  a  continuously  faster  dissolution  rate,  compared  to  image 
analysis data. Since this was not the case in the semi-static method nor in the dynamic ASA 
results, it can be speculated that the reason lies in the correction factor. Even if the pellets 
where  not  of  purely monohydrate  form in  the semi-static  method,  the  static  conditions 
would have allowed possible anhydrous substance on the surface of the pellet to convert 
into monohydrate form (e.g. Aaltonen et al. 2006). However, the flow agitation and the sink 
conditions inside the modified Einstein teacup could have been sufficient to remove any 
dissolved  anhydrous  form  from  the  surface  of  the  pellet,  thus  preventing  it  from 
recrystallizing as monohydrate (Hulse et al. 2012). In this case the dissolution rate would 
have been a combination of the dissolution rates of both theophylline monohydrate and 
anhydrous,  and  the  correction  factor  would  consequently  have  been  too  high.  This  is, 
however, only speculation and the actual case could be investigated by monitoring the solid 
state with e.g. in situ Raman spectrophotometry (Aaltonen et al. 2006). The anomalous TD2 
sample was again the sample with greatest difference in measured and predicted weight. 
The R2 value of 0.998 however signals a high correlation between the curve shapes, which 
can indicate a constant deviation over all data points, and could therefore be explained by 
an erroneous correction factor. It can be seen from the standard deviations in Figure 26 that 
no significant difference in variability between the image analysis data and the absorbance 
data exists. 
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Table 8.  Correlation of physical  and chemical analysis  data from the modified Einstein 
teacup single pellet experiments of theophylline (TDX) and acetylsalicylic acid (ADX), as 
well as physical factors affecting the results. Average values are presented with standard 
deviation in the relevant cases. The similarity factors (f2) and difference (f1) factors show 
the high similarity of physical and chemical analysis data 
Expeiment R2 f2 f1 Weighed mass 
(mg)
Predicted mass 
(mg)
Density 
(mg/mm2)
TD1 0.995 72 4 0.24 0.24 0.70
TD2 0.998 55 11 0.62 0.58 0.84
TD3 0.994 79 3 0.26 0.24 0.74
Average 0.996 ± 
0.002
69 ± 
12
6 ± 
4
0.37 0.35 0.76 ± 0.07
AD1 0.995 73 4 0.71 0.70 0.76
AD2 0.999 84 2 0.75 0.81 0.77
AD3 0.998 71 4 0.29 0.33 0.92
Average 0.997 ± 
0.002
76 ± 7 3 ± 
1
0.58 0.61 0.82 ± 0.09
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Figure 25. Collective theophylline single pellet dissolution curves of all three semi-static 
experiments,  from UV-spectrophotometric  (UV)  and  image  analysis  (Image)  data.  The 
absorbance data is constantly higher that respective image analysis data.
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Figure  26.  Average  (n=3)  theophylline  dissolution  curves  from  UV-spectrophotometric 
(UV) and image analysis  (Image) data from the modified Einstein teacup method, with 
standard  deviation.  No  difference  in  standard  deviation  is  observed  but  the  constantly 
higher values of the absorbance data can be seen.
The modified Einstein teacup dissolution data of ASA shows a very good correlation for all 
three experiments (Table 8). The average f2 and f1 values of 76 ±7 and 3 ±1 respectively, 
demonstrate the high similarity of the dissolution profiles. This is visualized in both the 
data from a single experiment (Figure 27) and in the combined data (Figure 28). Two out of 
three experiments ended at approximately 80% of the total time, and thus the  deviation 
towards the end of the image analysis data dissolution curve in Figure 29, is due to the 
weakness  of  the  third  degree  polynomial  fit  and  not  of  the  experimental  data.  A clear 
increase in the standard deviation of the absorbance data can however be seen before the 
80% time-point, which indicates the loss of accuracy of the UV-spectrophotometer at lower 
concentrations.
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Figure 27. Dissolution curves of physical (Image) and chemical (UV) analysis data from a 
modified  Einstein  teacup  acetylsalicylic  single  pellet  experiment  (AD2)  (left)  and  the 
correlation curve of the data sets (R2=0.999)(right).
0
20
40
60
80
100
0 10 20 30 40 50 60 70 80 90 100
Time (%)
Am
ou
nt
 d
is
so
lv
ed
 (%
)
Image UV
Figure 28. Collective acetylsalicylic acid single pellet dissolution curves of all three semi-
static  experiments,  from UV-spectrophotometric  (UV) and image analysis  (Image) data. 
Higher variations in absorbance data is observed towards the end, while image analysis data 
shows decreasing variation.
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Figure  29.  Average  (n=3)  acetylsalicylic  acid  dissolution  curves  from  UV-
spectrophotometric  (UV)  and  image  analysis  (Image)  data  from the  modified  Einstein 
teacup  method,  with  standard  deviation.  The  increasing  standard  deviation  of  the 
absorbance data is clearly observed, while all data past 80% on the Time axis are unreliable 
due to the weakness of the curve fit.
As in the case of the semi-static results, it can be observed from both theophylline and ASA 
dynamic  dissolution  data  that  the  single  experiments  often  produce  equal  or  higher 
correlation,  between physical  and  chemical  data,  than  the  average  data.  It  can  also  be 
observed from Figures 25 and 28 that the general trend for the image analysis data of the 
dissolving particles is towards smaller variation as the particle size decreases. This is not 
the case for the chemical analysis data, where a sometimes large increase in variation is 
observed as  the  samples  become more  dilute  and the  chemical  analysis  approaches  its 
limits. The smaller variation of the image analysis data is, however, not always reflected in 
the values calculated by intrapolation based on regression analysis, as can be seen in Figure 
29.  It can also be concluded that, as in the case of the semi-static data, the deviating results 
can be assumed to be caused by factors unrelated to the analytical accuracy of particle size 
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analysis.  The  one  common factor  of  all  deviating  results  was  the  higher  difference  in 
measured and predicted weight of the particle. This problem can easily be overcome using a 
more accurate scale. Also the limitations of the current dynamic setup, with regard to the 
number of data points and the image quality, are easily corrected using more sophisticated 
equipment.
15.2 Using the Hixson-Crowell cube root law to explain the obtained dissolution rate data
It was expected that a linear correlation of the obtained data with the Hixson-Crowell cube 
root law, would be achieved up until the time-point where the particle diameter decreased 
below 200 μm. This was because it has been theorized that the dissolution rate will start to 
notably increase below this particle size (Wang and Flanagan 1999). A significant increase 
would  also  be  expected  for  particles  below 50 μm,  when the  diffusion  layer  thickness 
would start to decrease (Hintz and Johnson 1989). The threshold diameter of 200 μm was 
however only crossed in two experiments, TD1 and TD3. In experiment TD3 the four last 
data points start to deviate from the relatively linear tendency of the previous data points. 
However, only the two last data points are below 200 μm and are calculated from images of 
suboptimal quality, which means that the uncertainty regarding the accuracy of the data has 
to  be  taken  into  account.  Therefore,  no  generalization  can  be  derived  from this  data. 
Experiment  TD1 (Figure  30)  had  five  data-points  below 200  μm,  which  means  that  a 
general tendency can be better investigated with this data. No significant increase towards 
the end of the curve can be seen in the TD1 dissolution profile, but a continuous increase 
can on the other hand be observed from the curved shape. This continuous increase can also 
be observed from the Hixson-Crowell rate constant (Equation 13) of sample TD1 (Figure 
31). 
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Figure 30. Hixson-Crowell cube root law correlation curve for dissolution data from single 
particle theophylline experiment TD1. Non-linear correlation can be observed.
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Figure 31. The change of the Hixson-Crowell rate constant, K with time for single particle 
theophylline  experiment TD1. A general increase can be seen.
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The data from all  ASA experiments however showed a high linear correlation with the 
Hixson-Crowell cube root law, of which one example is the correlation curve of the AD1 
experiment  in Figure 32.  When trying both first  and second degree fits  to the Hixson-
Crowell  cube  root  law  correlation  data  of  all  ASA and  theophylline  experiments,  the 
difference  in  dependency  is  demonstrated  (Table  9).  It  can  be  seen  that  while  all  the 
theophylline dissolution profiles show a clear increase in the R2 value when moving to a 
higher  order  polynomial  fit,  no or  minimal  change is  observed for the ASA data.  This 
constantly increasing dissolution rate of the theophylline pellets could indicate a continuous 
decrease of the diffusion layer thickness, which the Hixson-Crowell cube root law is not 
capable  of  modeling  (Macheras  and  Dokoumetzidis  2000).  According  to  the  Nernst-
Brünner  equation  (Equation  5)  a  constant  decrease  of  the  diffusion  layer  thickness,  h, 
would lead to a constant increase in the dissolution rate. 
However,  the dissolution behavior of theophylline is very complex,  due to the possible 
anhyrdate/monohydrate polymorph transformations (Lehto et al. 2008). As was shown by 
Aaltonen et al (2006), the phase transformation from anhydrate to monohydrate, in aqueous 
media, begins immediately after liquid immersion in a flow-through cell. They also showed 
that as the proportion of the monohydrate form increased, the dissolution rate accordingly 
decreased. This is in accordance with Equation 20, since the more stable monohydrate form 
will decrease the solubility, and thus the dissolution rate (Huang and Tong 2004). However, 
Hulse et al. (2012) who also studied the dissolution of anhydrous theophylline in a flow-
through cell, did not observe any conversion into monohydrate form. They speculated that 
the differing results of solid phase transformations, from different studies, might be due to 
different  hydrodynamics  of  the  experiments.  Neither  of  these  cases,  i.e. conversion  to 
monohydrate or stable anhydrate, can however explain the constantly increasing dissolution 
rate  of the present study.  There is  thus some additional factor involved that causes the 
dissolution rate to increase faster than what would be expected from the decreasing surface 
area of the Hixson-Crowell cube root model (Hixson and Crowell 1931). 
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Figure  32.  Hixson-Crowell  cube  root  law  correlation  curve  for  dissolution  data  from 
acetylsalicylic acid experiment AD1. A linear correlation is observed.
Table 9. R2 values for first  and second degree fits  to correlation curves of the Hixson-
Crowell  cube  root  law and  single  particle  theophylline  (TDX) and  acetylsalicylic  acid 
(ASX) dissolution data. A clear increased correlation is observed for theophylline pellets 
with a higher degree fit, whilst no or minimal increase is observed for acetylsalicylic acid 
pellets
Fit TD1 TD2 TD3 AD1 AD2 AD3
First degree    0.985      0.984      0.956      0.996      0.993      0.985   
Second degree    0.996      0.994      0.985      0.996      0.996      0.987   
15.3 The intrinsic dissolution rate of single particles
When assessing the IDR of a substance,  the exact surface area,  from which dissolution 
takes place,  has to be known. In the miniaturized IDR setup developed by Hulse et al. 
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(2012), where compressed discs of 3-10 mg of substance with a diameter of 2mm were 
characterized  by UV area  imaging,  a  similarity  was  found  with  disc-IDR results  from 
literature. The similarity was however not further specified. Tsinman et al. (2009) were able 
to  produce  IDRs,  comparable  to  results  from  standard  disc-IDR  measurements,  from 
powder  samples  as  small  as  0.06 mg.  The  surface  area  of  this  multiparticulate  sample 
would,  however,  have been significantly higher  than that  of  a  single  particle.  In single 
particle dissolution studies, a constant monitoring of the dissolving particle surface area has 
to be performed in order to assess the IDR. This is not possible when using only chemical 
analysis, such as UV area imaging. Parrott et al. (1955) assessed the dissolution from a 
single spherical particle of the initial radius of 1.27 cm, and calculated the mass dissolved 
per time and radius, not surface area. This large particle will not, however, have been very 
representative of real drug particles of bulk powders. Börjesson et al. (2013) assumed a 
cylindrical  shape  of  their  fixed  pellets,  and  calculated  IDRs  for  the  single  dissolving 
cylinders, based on a theoretical mass transport coefficient. The mass transport coefficient 
was calculated through simulation of the flow profile in the flow-through cell. They where 
able to show some similarity of, particle and time averaged, IDR data with disk-IDRs from 
literature.  Due  to  the  fact  that  they  were  not  able  to  calculate  the  IDR for  individual 
particles, their result cannot be regarded as single particle IDR.
In the present study, the intrinsic dissolution rate from single particle image analysis data 
produced clearly consistent results (Table 10). It is the first time that the IDR has been 
calculated from an individual experiment of a single three-dimensional surface. It is also 
the first time that the IDR has been calculated from a single particle of a drug substance, 
and from a single drug particle of in vivo relevant size. The average IDRs for theophylline 
and  ASA single  pellets  where  2.81  ±  0.22  mgcm-2min-1 and  1.76  ±  0.07  mgcm-2min-1 
respectively. The results are not directly in line with IDRs from literature, in which IDR 
results  of  0.9  mgcm-2min-1 (pH  6.8,  37°C)  for  both  theophylline  and  ASA have  been 
reported (Peltonen et al. 2003; Peltonen et al. 2004). The single particle IDRs are, however, 
clearly reflected in the dissolution times of the theophylline and ASA experiments, where 
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the increase in experiment duration is approximately twice the decrease in IDR (Table 10). 
There is also a clear correlation between the ratio of the solubilities (Table 4) and the ratio 
of the IDRs for theophylline vs. ASA, both of which are 1.6. Also the consistency of the 
data as shown in Figures 33 and 34 cannot be ignored. 
Table  10.  The  intrinsic  dissolution  rates  of  single  pellets  of  theophylline  (TDX)  and 
acetylsalicylic acid (ASX), and the duration of the experiments. Mean values are presented 
with standard deviation. It can be seen that the increase in the duration of the experiments is 
approximately twice the decrease in IDR
 TD1  TD2  TD3 Average  AD1  AD2  AD3 Aveage
IDR (mgcm-2min-1) 2.85 2.58 3.01 2.81 ± 0.22 1.79 1.80 1.68 1.76 ± 0.07
Duration (min) 34 49 29 37 91 86 82 86
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Figure 33. The change in the intrinsic dissolution rates of theophylline single pellets (TDX) 
with time.  The individual  pellet  results  are  clearly consistent  and a  slight  tendency for 
increased rates can be observed, after the initial onset lag time.
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Figure 34. The change in the intrinsic dissolution rates of acetylsalicylic acid (ADX) single 
pellets with time. As with the theophylline pellets, the individual pellet results are clearly 
consistent and a slight tendency for increased rates can be observed, after the initial onset 
lag time.
The deviation from literature IDR data cannot be explained by differences in dissolution 
media. Since the dissolution medium used in the present study was degassed distilled water, 
the pH was close to  7.  Additionally the average temperatures  of  the dissolution  media 
where  23  ±  0.4°C  and  23  ±  0.7°C  for  the  three  theophylline  and  ASA experiments, 
respectively. The slight difference in pH is not enough to explain the differences, and in the 
case of theophylline,  with a pKa of 8.81 (Table 4),  the higher pH of the present study 
should have produced slower dissolution rates, in accordance with Equation 22. The lower 
temperature should also,  in accordance with  Equations 3 and 6,  have resulted in lower 
IDRs. One possible explanation can however be the particle size. It can be seen in Figures 
33 and 34 that there is a tendency, for both theophylline and ASA pellets, towards increased 
IDRs with decreasing particle size. For a large compressed tablet the IDR could therefore 
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very well decrease to the levels presented in literature. Another possible explanation is the 
difference in hydrodynamics, of the modified Einstein teacup and other methods, which 
have been shown to produce differing intrinsic dissolution rates for different liquid flow 
dynamics (Lehto et al. 2008, Hulse et al. 2012). This effect is also derived from the Levich 
equation  (Equation  18),  where  the  angular  velocity  of  the  rotating  disc  is  directly 
proportional to the disc-IDR. The initial high variability which can be seen in the IDR data 
in Figures 33 and 34, could imply a lag time of wetting and diffusion layer buildup. It could 
also be caused by the swelling and consequent disintegration of the particle surface, when 
coming into contact  with the dissolution medium (Marabi  et  al.  2008;  Börjesson et  al. 
2013). It can be seen when following a data set from the beginning, that the data seems to 
oscillate in a kind of pulsating motion between high and low IDRs. It is therefore possible 
that the pulsating profile is due to some kind of dynamic diffusion layer buildup. To the 
knowledge of the author, only already formed diffusion layers and the decrease in these, 
with  decreasing  particle  size,  has  been  investigated  (e.g. Hintz  and  Johnson  1989; 
Mosharraf and Nyström 1995; Galli 2006).
An interesting occurrence was also observed when comparing the IDRs to  the Hixson-
Crowell rate constants of the respective experiments (Figures 35 and 36). It was found that 
the IDR values, over all data points of all six dynamic experiments, where on average 212 
±16 (n=252) times larger than the respective Hixson-Crowell  rate constant values. This 
means that the cumulative amount dissolved per average surface area (Equation 17), at a 
specific time, is directly proportional, by a constant of around 200, to the difference of the 
cube roots of the initial weight and the weight of the particle at that specific time (Equation 
13). It is not immediately apparent why this would be the case, however, the weight of a 
spherical particle relates directly to the surface area of that particle, trough volume and 
density. The same equivalent sphere surface area, that was used fore IDR calculations was 
also used to calculate the mass of a pellet. To the knowledge of the author, this relationship 
has  not  been  previously  assessed,  and  could  be  further  investigated.  Since  the  high 
solubility  IDR  threshold  for  biopharmaceutics  classification  is  1-2  mgcm-2min-1,  both 
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theophylline and ASA are placed in the correct BCS classes of BCS class I and BCS class 
III respectively (Lindenberg et al. 2004; Zakeri-Milani et al. 2009). It has been previously 
shown that the BCS classification can be done based on the disc-IDRs of drug substances 
(Yu et  al.  2004; Zakeri-Milani et  al.  2009). This is,  however,  the first  time it  has been 
demonstrated that the BCS classification can be determined from a single drug particle. 
0
0.5
1
1.5
2
2.5
3
0 10 20 30 40 50 60 70 80 90
Time (min)
ID
R 
(m
g/
cm
2 /
m
in
)
Figure 35. Change in the intrinsic dissolution rate with time of the AD2 experiment.
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Figure  36.  Change  in  the  Hixson-Crowell  rate  constant,  K  with  time  of  the  AD2 
experiment.
16 FUTURE PROSPECTS
The  analyzed  images  in  the  present  study,  were  collected  with  an  inexpensive  digital 
microscope using manual image processing and public domain image analysis software. 
Even when using these simple techniques, the acquired dissolution data was practically 
identical  with  data  from commonly used  chemical  analysis.  It  is  also  inferred  that  the 
occasional lower correlations,  between some physical  and chemical  analysis  dissolution 
profiles,  can  be  explained  by  the  inaccuracies  of  weighing,  and  of  determining  the 
absorbance of dilute samples. Therefore, by using more sophisticated equipment, the results 
can only get better. It is thus proposed that image analysis can be used, on its own, as a 
viable analytical technique in single particle dissolution studies. 
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The possibility of using optical microscopy, without the need for simultaneous chemical 
analysis, poses many advantages. In contrast to common chemical analysis techniques, no 
calibration  using  the  investigated  substance  is  needed,  therefore  decreasing  substance 
consumption.  The  only  primary  information  required  for  physical  analysis,  by  optical 
microscopy,  is  the  initial  mass  of  the  studied  particle.  Additionally  there  is  no  sample 
preparation  steps  involved,  eliminating  many  possible  sources  of  error.  Moreover,  the 
simplicity  of  the  technique  and  the  possibility  of  rapid  information  collection,  makes 
studying  the  dissolution  by  image  analysis  highly  adaptable  to  automation  and  higher 
throughput screening.
The novel modified Einstein teacup flow-through method, developed in the present study, 
was successful in creating a collecting flow, keeping the single freely rotating particle in a 
sufficiently  small  area  to  allow  continuous  image  acquisition.  It  is  the  first  analytical 
apparatus, with which it is possible to continuously assess the dissolution rate of a freely 
moving  single  particle,  in  a  flowing  liquid.  The  rudimentary  prototype,  consisting  of 
practically two needles and a 96-well plate chamber,  is very inexpensive and simple to 
build, and is therefore easily duplicated for parallel dissolution studies. The flow-through 
setup also gives an additional advantage, by allowing the use of in vivo relevant dissolution 
conditions.  The  flow rate  can  be  adjusted  to  reflect  in  vivo flow rates  of  0-7  ml/min 
(Dressman et al. 1998). The optical method also works with any transparent liquid, which 
means that biorelevant media, as well as buffered solutions of any pH can be used in the 
dissolution studies.  Additionally the flow-through allows the possibility of  dynamic pH 
gradient runs, for the obtaining of pH-dependent dissolution rates (Okumu et al. 2008).
The developed technique also allowed the obtaining of intrinsic dissolution rates for the 
substances used, from the data of individual single particle experiments. This means that 
the solubility of a substance can be predicted from solid dissolving particles, producing 
much more accurate predictions of thermodynamic solubility, than the data acquired from 
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kinetic  solubility  studies  of  predissolved  substance  (Yu  et  al.  2004).  Furthermore  the 
intrinsic dissolution rates allow the prediction of the BCS class of a drug substance, from a 
single dissolving particle, which could be of great value in the early drug development. 
Because  the  rotating  particle  makes  it  possible  to  assess  the  3D  particle  shape,  it  is 
perceived that by using appropriate shape factors, the modified Einstein teacup apparatus 
can be used to determine the dissolution rates of single particles of any particle shape. 
Using this technique, it is therefore possible to acquire quantitative data of physicochemical 
parameters, which are currently assessed qualitatively with kinetic solubility methods or in  
silico calculations, very early in the drug discovery and development process (Figure 37).
Figure 37. The current state of solubility and dissolution rate assessment in drug discovery 
and early development (gray boxes), and the possibility of moving mini-scale dissolution 
testing to earlier stages (pale dotted arrow), with novel mini-scale techniques (modified 
from Sugano et al. 2007).
The novel apparatus is also very adaptable. If the vortex is produced by a stirrer rather than 
by the liquid flow of the current prototype, any flow rate could be used. The dissolution 
could then also be studied under diffusion controlled stagnant conditions, under diffusion 
and solubility controlled agitated conditions or under solubility and intrinsic dissolution 
rate  controlled  sink  conditions.  If  regarded  as  appropriate,  other  physical  or  chemical 
analysis  techniques,  including  turbidimetry,  area  imaging,  in-line,  on-line  or  off-line 
techniques  as  well  as  in  situ probes,  could  be  used  in  the  apparatus.  Furthermore  the 
possibility  of  real-time  monitoring  of  solid  state  properties  and  transformations  by  i.e. 
Raman spectroscopy is another interesting possibility (Aaltonen et al. 2006). This would 
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allow the direct correlation of solid state properties with dissolution rate data (Tong et al. 
2009). The technique is also not confined to only single particle experiments, but could 
additionally be used to study multiparticulate samples.
There  is  no other  current  technique that  allows the assessment  of  dissolution  of  freely 
moving single particles from 3D morphological data. In addition to real-time assessment of 
surface specific dissolution rates, the 3D data could be used to construct virtual models of 
the  single  particles.  This  would  allow  the  exact  in  silico investigation  of  surface 
topographic dissolution rates, as well as an accurate simulation of particle size dependent 
dissolution rates. As the development process moves forward, the aim is to maximize the 
quality of the collected data, by optimizing the apparatus and by using more sophisticated 
equipment. The aim is also to reduce the size of the studied single particles, and thus also 
the materials consumption, as well as to study the dissolution of particles of varying shapes. 
The realistic threshold of around 1 μm for particle size analysis, poses limitations for the 
optical analytical technique (Allen 1997). However, using particles with the initial diameter 
of 10 μm, would mean a hundred-fold decrease, from the current setup. This, accordingly, 
would mean a million-fold reduction in particle volume and mass. The realistic lower limit 
for  single  particle  dissolution  testing  by  this  novel  technique  is  therefore  around  an 
unprecedented 1 ng in initial particle weigh, if an accurate assessment of the weight can be 
made. As this nanogram particle dissolves to the limit of 1 μm, its weight will have been 
reduced to 1 pg.
17 CONCLUSIONS
Through the work of the present study it can be concluded that:
• Image analysis produces practically identical dissolution profiles with conventional 
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chemical analysis. Optical microscopy is therefore a viable analytical technique for 
single particle dissolution testing;
• The possibility of using physical analysis instead of chemical analysis poses many 
advantages. These include reduced materials consuption, reduced experiment times 
as well as a reduction in the possible sources of error;
• The main advantage of physical analysis over chemical analysis is, that no prior 
chemical knowledge about the studied particle is needed. Physical analysis is thus 
the optimal technique for analyzing new chemical entities;
• The novel modified Einstein teacup flow-through dissolution technique provides the 
first method, with which it is possible to determine the dissolution rate of freely 
moving single particles, through continuous physical analysis;
• The possibility  of  investigating  the  dissolution  from a  single,  three-dimensional 
surface,  significantly  decreases  the  assumptions  involved  in  dissolution 
assessments, and allows the extrapolation of the data to any effective surface area;
• Single-particle dissolution is not always accurately modeled by the Hixson-Crowell 
cube root law. Since this was the theoretically ideal model for the studied spherical 
pellets, it shows the potential weakness of  in silico modeling based on theoretical 
equations;
• By the novel method developed in this study, it is possible to obtain the intrinsic 
dissolution rate from a single drug particle. Thus, as was shown, it is also possible 
to predict the BCS classification of a drug subtance, from a single particle;
• The wide adaptability and the relatively simple improvement, of the already very 
good data, could make this novel dissolution technique an attractive possibility for 
early  qualitative  physicochemical  screening,  in  drug  discovery  and  early 
development. This is especially true, if the theoretical picogram detection limit is 
achieved.
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